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Epidemiological Study of Contributing Factors in the Development of Peptic Ulcer and
Gastric Cancer Initiated by Helicobacter Pylori Infection in India
Rahul Suresh Mhaskar
ABSTRACT

Background: Helicobacter pylori (H. pylori) infection is a significant risk factor for
peptic ulcer (PU) and gastric cancer (GC). Apart from the virulent CagA genotype of H. pylori
environmental and dietary factors influence disease outcomes. There have been no studies
addressing these factors in Western India. Hence, we conducted a case control study enrolling
PU, GC patients and controls at Pune, India.
Methods: Risk factors for PU and H. pylori infection were assessed in participant
interview. H. pylori status was assessed from stool by monoclonal antigen detection. To
understand treatment effect, we followed 100 H. pylori positive patients.
Results: We enrolled 190 PU patients, 125 Controls and 35 GU patients. Prevalence of H.
pylori was 61% among symptomatic patients and 45% among controls. H. pylori infection (OR:
1.70, 95% CI: 1.03-2.89), meat (OR: 1.10, 95% CI: 1.02-1.75), fish (OR: 1.05, 95% CI: 1.021.89) consumption, and family history of ulcer (OR: 1.20, 95% CI: 1.08-1.60) were risk factors
for PU. Consumption of snacks with alcohol (OR: 0.32, 95% CI: 0.13-0.78) and history of antiparasite treatment (OR: 0.51, 95% CI: 0.30-0.86) were protective factors against PU. Lower
socioeconomic status (SES) (OR: 1.10, 95% CI: 1.02-1.39), meat consumption (OR: 2.35, 95%
CI: 1.30-4.23), smoking (OR: 2.23, 95% CI: 1.24-4.02), eating restaurant food thrice per week
(OR: 3.77, 95% CI: 1.39-10.23) and drinking non-filtered or non-boiled water (OR: 1.05, 95%
CI: 1.01-1.23) were risk factors for H. pylori infection. Consumption of chili peppers (OR: 0.20,
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95% CI: 0.10-0.37) and concurrent parasite infestation (OR: 0.44, 95% CI: 0.24-0.80) were
protective against H. pylori infection. H. pylori infection was eradicated only in 53% (40/75) of
treated patients.
Conclusion: This study indicates that H. pylori infection is associated PU. Consumption
of meat, fish and family history of PU are risk factors for PU. Lower SES, consumption of
restaurant food, meat, non filtered water and smoking are risk factors for H. pylori infection.
Consumption of chili peppers and concurrent parasite infestation are protective against H. pylori
infection while history of anti parasite treatment protects against PU. H. pylori were eradicated
only in 53% of patients.
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Chapter One
Introduction
Background
The Medicine Nobel Prize of 2005 was awarded to an observant pathologist Robin Warren and an
enterprising physician Barry Marshal, both from Australia, for the discovery of Helicobacter
pylori (H. pylori) and its role in peptic ulcer disease and gastritis in 1983.[1] Since its discovery,
the organism has generated tremendous interest among the medical researchers. H. pylori are a
micro-aerophilic, highly motile, gram-negative spiral organisms with 4-6 flagella at one end. The
organism has the striking biochemical characteristic of abundant urease enzyme production. H.
pylori have a special affinity for gastric mucosa and is etiologically associated with chronic active
gastritis, peptic ulcer (duodenal and gastric) and gastric cancer.[1] Chronic gastritis induced by H.
pylori is usually not symptomatic but is considered to be the background of several diseases, i.e.,
peptic ulcer and gastric malignancies that typically occur in adulthood.[2] H. pylori infection is
almost always acquired in early childhood and usually persists throughout life unless a specific
treatment is given (spontaneous eradication is rare). H. pylori infects at least 50% of the world’s
human population [3] and poor socio-economic condition is regarded as the most important risk
factor for acquisition of the infection.[2, 4]
The inside of the stomach is bathed in about half a gallon of gastric juice every day. Gastric juice
is composed of digestive enzymes and concentrated hydrochloric acid, which can readily tear
apart the toughest food or microorganism. Bacteria, viruses, and ingested food are all consumed
in this deadly bath of chemicals. It used to be thought that the stomach contained no bacteria and
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was actually sterile, but H. pylori changed that. [5]
The stomach is protected from its own gastric juice by a thick layer of mucus that covers the
stomach lining. H. pylori take advantage of this protection by living in the mucus lining. Once H.
pylori is safely ensconced in the mucus, it is able to fight the stomach acid that does reach it with
an enzyme it possesses called Urease. Urease converts urea, of which there is an abundant supply
in the stomach (from saliva and gastric juices), into bicarbonate and ammonia, which are strong
bases. This creates a cloud of acid neutralizing chemicals around the H. pylori, protecting it from
the acid in the stomach. The reaction of urea hydrolysis is important for diagnosis of H. pylori by
the breath test (UBT). Another defense H. pylori has is that the body's natural defenses cannot
reach the bacterium in the mucus lining of the stomach. The immune system will respond to an H.
pylori infection by sending white cells, killer T cells, and other infection fighting agents.
However, these potential H. pylori eradicators cannot reach the infection, because they cannot
easily get through stomach lining. They do not go away either and lead to strengthened immune
response. Polymorphs die, and spill their destructive compounds (superoxide radicals) on
stomach lining cells. Extra nutrients are sent to reinforce the white cells, and the H. pylori can
feed on this. This process results in gastritis and may eventually lead to peptic ulcer and / or
stomach cancer. It may not be H. pylori itself which causes peptic ulcer, but the inflammation of
the stomach lining; i.e. the response to H. pylori. [6]

Transmission of Helicobacter pylori
The reservoirs of H. pylori appear to be numerous, but the exact mode of transmission still
remains unproven. In developing countries, poor sanitation makes the feco-oral route the most
common route of transmission.[7] Dirty water, milk adulterated by dirty water, or consumption of
uncooked vegetables irrigated with or washed in water contaminated by human excrement is
believed to be responsible. In the developed world, oral-oral transmission is likely to be the
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dominant route, especially in situations where there is overcrowding, and more so among
children. [8]
In addition, communal eating habits and the parental practice of masticating food for children at
weaning could be vehicles of infection transmission.[9] Young children also experience repeated
colonization of the oral cavity by regurgitation, emphasizing the importance of the gastro-oral
route. [10] Saliva and dental plaque can harbor H. pylori, and saliva could act as a vehicle of
transmission. One of the most proven modes of transmission is via gastric intubation experiments
or gastroscopy and removal of biopsy tissue from the stomach by non-disposable forceps.[10, 11]
The conversion of H. pylori into viable but non-culturable coccoid form during adverse
conditions and re-growth into the spiral vegetative form when conditions are favorable is a
particularly intriguing concept. [12]

Changing prevalence of H. pylori infection
The prevalence of H. pylori is different worldwide. In the United States infection is low among
white and economically advantaged Americans. However, minority populations have a higher
frequency of infection: United States data indicate that African American children aged 5 to
9 years have an overall infection frequency of 30%. Around the world, infection among children
ranges from approximately 35% in Russia to 20% in China and Poland, 12% in Korea and
America to <10% in France, Belgium and Finland.[13] [14] [15] [16-20] Despite high rates of
infection in certain pockets of the globe, the frequency of H. pylori infection is declining
worldwide. For instance, in one study conducted in Matsumoto, Japan, the rate of infection
declined by up to 20% between 1986 and 1994 among individuals aged 9 to 70 years of age. [14,
21]
A recent study from Russia examined the effect of recent improvement in standards of living on
the prevalence of H. pylori in Russian children by conducting 2 cross-sectional studies among
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children in St. Petersburg. The first study was undertaken in 1995 and the second a decade later.
H. pylori status was evaluated using the same ELISA method for anti H. pylori IgG (HM-CAP).
The research found that the initial overall prevalence of H. pylori infection was 44% and
decreased to 13% ten years later. In both studies, the prevalence increased with age. In 1995 the
prevalence was 30% among children younger than 5 years. A decade later the prevalence in the
same age group is 2%. The authors concluded that improvements in the standard of living in
Russia have resulted in a marked reduction in H. pylori transmission. Different rates of
acquisition H. pylori form the basis for the differences in prevalence of infection between and
among populations. The changes in Russia are a dramatic example of how sensitive H. pylori
acquisition is to improvement in standards of living.[14]
This finding regarding socioeconomic status (SES) during childhood holds true for all subgroups
in the United States. For instance, in a pediatric study conducted in Arkansas, children coming
from a family with an income of <$5,000 had up to a 60% rate of infection between the ages of
11 and 20 years, whereas those with a family income of >$25,000 had only a 15% rate of
infection.[4] This phenomenon has also been observed in other countries. In recently developed
countries, such as Korea although approximately 80% of individuals >20 years of age are
infected; the prevalence of infection in young children is inversely related to the socioeconomic
class of their family. Those aged 10 to 19 years who are in a high socioeconomic class had a 20%
frequency of H. pylori infection, while those of the same age who are in a low socioeconomic
class have a 60% frequency. [15]
A study from Kazakhistan was conducted among unrelated asymptomatic individuals between the
ages 10 and 60 years and examined various aspects of the local household environment and
access to water. [22] The study reported that transmission of H. pylori is largely opportunistic and
can be water borne. If the rate of H. pylori transmission is to be reduced it will require an
improvement in overall sanitation including waste disposal, clean water, and safe food as well as
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in household hygienic practices. A cross sectional study conducted in children residing in
industrial and rural areas in Italy reported that the sero-prevalence of H. pylori infection was
significantly higher in children residing in rural areas compared to those in industrial areas. [23]
The study also found that in rural areas, children having dogs were at greatest risk for H. pylori
acquisition but this effect was not observed among children from the industrial areas.
Prevalence of gastric cancer in Asian countries
There is a marked international variation in gastric cancer incidence with highest rates reported
from Japan. It is interesting to note that despite Japan being a developed country with a lower
frequency of H. pylori infection; it has highest frequency of gastric cancer. Similarly, frequency
of gastric cancer is quite high in China despite a lower frequency of H. pylori infection. In
contrast, people living in less developed countries of Asia with high frequency of H. pylori
infection [24-31] that is acquired at an earlier age have the lowest risk of developing gastric
cancer.[32] It has also been observed that frequency of gastric cancer differs in different parts
within many countries; for example, in Japan [33], variation in gastric cancer risk has been well
documented in different regions and has been presumed to be related to variation in nutrient
consumption. In China [34], gastric cancer mortality in Changle county is about 10-fold higher
than that in Hong Kong and has been attributed to variation in frequency of H. pylori infection in
the two regions. In India the prevalence of H. pylori has been reported in the range of 60 % to
80%. [27, 35-38] In India, southern [39] and eastern parts (personal observation) of the country
experience somewhat higher frequency of gastric cancer than the western and northern parts of
the country. This may be attributed to the underlying variation in the diet, host genetics and
genotype of H. pylori between these diverse populations. Interestingly, similar epidemiological
observations were made long ago in India in respect of another H. pylori related gastro-duodenal
ailment, i.e., peptic ulcer disease. [40]
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Peptic ulcer and gastric cancer in India
Studies from India have shown an association between H. pylori infection and peptic ulcer.[31,
41, 42] However, studies from India failed to show an association between H. pylori infection and
gastric cancer.[43-45] In a study on 50 patients with gastric cancer and 50 controls with non-ulcer
dyspepsia, H. pylori infection was detected less frequently in gastric cancer (38%, 19/50) than
those with non-ulcer dyspepsia (68%, 34/50).[43] Another study demonstrated that 64.7% (33/51)
patients with gastric carcinoma and 74.4% (32/43) with non-ulcer dyspepsia had infection with H.
pylori.[44] These studies can be criticized due to small sample size with a consequent type II
statistical error. However, these studies had inadequate reporting of follow up time. Similarly, in
most of these studies, endoscopy-based tests were used to diagnose H. pylori infection. Since H.
pylori is less likely to survive in a stomach lining with metaplasia. Endoscopy-based tests can be
false negative in patients with gastric cancer due to gastric atrophy and intestinal metaplasia .[46]
However, studies from China and Japan showed association between H. pylori infection and
gastric cancer. [47, 48] In essence, studies from India support the role of H. pylori as the most
important risk factor for peptic ulcers while studies elucidating association between H. pylori and
stomach cancer suffer from poor methodological quality.
There are some countries like India with highest frequency of H. pylori infection have the lowest
risk of gastric cancer in contrast to the countries like Japan and China where gastric cancer risk is
highest in the world despite a lower occurrence of H. pylori infection. This casts major objection
to some of the simplified model of gastric carcinogenesis resulting from H. pylori infection that
stated that if the infection is acquired at an early age particularly in presence of malnutrition, it
may reduce gastric acid secretion, pangastritis and gastric cancer may be the likely outcome. In
contrast, infection acquired later in life and in person with good nutritional status and normal
gastric acid secretion would result in hyperchlorhydria and duodenal ulcer disease.[49] It is well
documented in the literature that patients with duodenal ulcer infrequently or never develop
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gastric cancer.[50] If this simplified model of gastric carcinogenesis would have been true, India,
Bangladesh, Pakistan would have higher frequency of gastric cancer than Japan and China.[48]
However, this is certainly not the case; there are certain factors apart from H. pylori infection
such as dietary and environmental factors which modulate the prevalence of these diseases. In
summary there are various factors along with H. pylori infection which determine the disease
outcome. These factors are broadly classified into agent factor, host factors and environmental
factors.

Risk factors for H. pylori infection
Agent factors: Cag pathogenicity island and CagA
The Cag pathogenicity island (PAI) qualifies as an important virulence factor. Its presence is
associated with an increased risk of peptic ulcer and gastric cancer. Biologically, the Cag PAI is
associated with enhanced mucosal inflammation both in vivo and in vitro. The Cag PAI encodes
a type IV secretory apparatus (a molecular syringe) that injects the CagA protein and other
bacterial products into eukaryotic cells. [51] Most H. pylori in the world contain the Cag PAI,
and the risk of a clinical outcome is significantly increased in association with its presence.
However at times peptic ulcer and gastric cancer can occur in individuals infected with Cag PAI
negative H. pylori. Even within regions where essentially all H. pylori contain the Cag PAI, there
are marked regional differences in cancer risk, which confirms that disease outcome involves an
interaction among host, environment, and bacterial factors. [51]
So it appears that all strains of H. pylori are not pathogenic. Is it possible that people living in
countries with lower frequency of gastric cancer are infected with non-pathogenic strains of H.
pylori than people living in China or Japan? Peptic ulcer disease, which is associated with
infection by pathogenic strains of H. pylori, has been reported a common problem in India and
Bangladesh.[48]
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Genotypic analysis of H. pylori strains from India showed pathogenic strains to be present in
more than 80% of adults and children with gastro-duodenal diseases as well as in control
population.[52, 53] Studies that used CagA antibody in patients with non-ulcer dyspepsia have
shown that CagA antibody is detected in sera of most patients.[54] A recently completed large
study on 279 patients with gastric neoplasms (263 gastric cancer and 16 primary gastric
lymphoma) and controls (101 non-ulcer dyspepsia and 355 healthy subjects) showed that
frequency of CagA IgG antibody was similar among the patients with gastric carcinoma and the
controls, suggesting that difference in virulence factor of H. pylori, at least CagA alone, is
unlikely to explain the variation in outcome of H. pylori infection.[55]
So, some environmental factors and host genetic factors along with bacterial virulence factors
such as CagA are interplaying leading to diseases. In a study from US, Korea and Colombia [56]
in which the first-degree relatives of patients with gastric cancer were evaluated to know whether
similar strains of H. pylori or similar environmental factors are responsible for pattern of gastritis.
However, this study failed to show any relationship between specific virulence factors or H.
pylori strains and specific histologic pattern or outcome even among those sharing the same
environment in childhood. [56] However, several studies from Japan and China [57, 58] showed
that virulence factors of H. pylori are strongly associated with gastric carcinoma. Based on the
available evidence, one cannot conclude that in Asian countries, despite high frequency of H.
pylori infection, low frequency of gastric cancer is related to infection with only non-pathogenic
strains. We are not aware of any studies that document the prevalence of the most virulent East
Asian compared to less virulent Western CagA genotype in population from India. Indeed there
are other factors such as host genetic factors and environmental factors at play which may explain
this dilemma. [59]
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Host genetic factors
Host’s genetic make-up determines in a major way response to any infection, including that to H.
pylori. This is evidenced by the fact that relatives of patients with gastric cancer infected with H.
pylori developed precancerous abnormalities like gastric atrophy and hypochlorhydria more often
than those with non-ulcer dyspepsia. [60] Patients with duodenal ulcer, which is also caused by
H. pylori, do not develop gastric cancer in contrast to other conditions associated with H. pylori
infection, such as gastric ulcer, non-ulcer dyspepsia and hyperplastic gastric polyp. [61] These
also depict variations in host’s response despite infection with the same organism. Japanese
immigrants to the United States have higher gastric cancer risk than native born Americans,
though lesser than Japanese living in Japan [48]; this suggests the importance of the genetic
factors with additive effects of environmental factors. Difference in carcinogenic risk in people
living in different geographical areas might be related to variation in genetic make-up among
different races. Specific allelic variation of different genes (polymorphism) present in a
proportion of general population may determine variation in carcinogenic potential in different
populations in response to environmental carcinogenic exposure, including that to H. pylori
infection.[62] Genetic susceptibility of a person may be important in a number of carcinogenic
processes that include: 1) mucosal protection against H. pylori infection and injury by other
carcinogens; 2) mucosal inflammatory response to infection with H. pylori; 3) degree of apoptotic
cell death; 4) carcinogen activation and detoxification by various enzyme systems of the hosts;
5) variability in the repair of mutated DNA; and 6) ability of the cell to proliferate in a controlled
manner to repair the damage.
Several studies have been carried out on single nucleotide polymorphism in relation to gastric
carcinogenesis. [62] However, many of these studies did not take into account the role of H.
pylori infection and dietary factors in addition to the genetic factors. Therefore, there is need of
more data on genetic polymorphism in relation to H. pylori infection and dietary factors.
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It is impossible entirely to separate environmental factors from genetic influences. An early twin
study on Swedish population suggested that there was a genetic component for acquiring H.
pylori infection and a follow-up study on the same twins’ population has questioned if there are
genetic influences for peptic ulcer disease in common with genetic influences for H. pylori
infection. [63] Comparisons of mono-zygotic and di-zygotic cross-twin and cross-trait
correlations in that study demonstrated that despite the similarity in heritability for the two traits
(peptic ulcer disease and H. pylori infection), the genetic influences for liability to peptic ulcer
disease are independent of such genetic effects for acquiring H. pylori infection. It is feasible that
the relationship between H. pylori and peptic ulcer disease could be mediated by familial
environmental factors, (i.e. environmental experiences or situations that are shared by family
members). Examples of some familial environmental factors that may mediate the association
between H. pylori and peptic ulcer disease are diet, smoking, or drug consumption (e.g., alcohol,
caffeine, non steroidal anti inflammatory drug consumption). [14]
Dietary and environmental factors
Diet may play a major role in gastric carcinogenesis. In India, southern [39] and eastern parts
(personal observation) of the country experience somewhat higher frequency of gastric cancer
than the northern parts of the country. Rice is the staple cereal in eastern India. Non-vegetarian
foods, particularly fish, are very common in eastern Indian diet, which is also spicy with more
salts. Diet in southern India is somewhat similar to that in eastern India with rice, fish, excess
spice and salt being commonly eaten. In contrast, northern Indian diet is mainly wheat-based and
a greater proportion of people are vegetarian. Tobacco smoking, high-temperature food intake,
spicy food and rice eating have been shown to be risk factors for gastric cancer in India.[64] In
another study, consumption of dry fish has been shown to be a risk factor for gastric cancer in
India.[65] Diet has been considered to be a major factor for increased frequency of gastric and
esophageal cancer in Kashmir province of India.[41] Similar observations have also been made in
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several countries, including Japan where northern districts have reported a higher frequency of
gastric cancer than southern district and this has been related to increased dietary intake of salts in
northern districts.[32] Tobacco use and alcohol consumption are the other factors that may
influence the international variation in frequency of gastric cancer.[66]
There are certain protective factors against H. pylori infection and diseases caused by it.
Interestingly there are certain elements in the diet which are noted be a protective factor against
H. pylori and in turn lowering the risk of peptic ulcers and gastric cancer. Some examples are
ginger, chili peppers, and turmeric.[67-70]
Another protective factor against disease caused by H. pylori infection which is recently shown
promise in the research is concurrent helminth infection. Interestingly concurrent enteric helminth
infection has shown to modulate inflammation and gastric immune responses and reduces
helicobacter-induced gastric atrophy.[71] It is well know that the progression of helicobacterinduced gastritis and gastric atrophy mediated by type 1 T-helper cells may be modulated by
concurrent parasitic infection. [71] Here, in mice with concurrent helminth infection,
helicobacter-associated gastric atrophy was reduced considerably despite chronic inflammation
and high helicobacter colonization. [71] Thus, concurrent enteric helminth infection can attenuate
gastric atrophy, a premalignant lesion. Moreover in a study conducted among children in
Columbia suggest that intestinal helminthiasis in children promotes Th2-polarizing responses to
H. pylori and may decrease gastric cancer risk in these individuals later in life. [72] Concurrent
helminthiasis may alter inflammatory responses to H. pylori and thus affect the progression of
gastritis to gastric atrophy, dysplasia, and cancer. [72]
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Summary of risk factors for H. pylori infection
In summary, it is estimated that 50% of the world’s population is infected with H. pylori and
approximately 20% will develop peptic ulcer disease.[73] Factors that may influence the
acquisition of H. pylori infection are geographic area, age, race, ethnicity, and SES.[74] The
prevalence of H. pylori infection in developing countries can be >80% in children under 10 years
old and in developed countries it can be up to 50% of children living in poor socioeconomic
conditions.[75] High prevalence of infection have been reported in India, Africa, Latin America,
and eastern Europe.[73] A study of a population from, the US-Mexico border, found a higher H.
pylori sero-prevalence among preschool children in a developing country than in a developed
country location indicating that geographic variation is an important risk factor.[76] Other risk
factors that have been associated with high prevalence include having an infected mother [77], an
infected older sibling [78], low SES, household crowding, migration from high prevalence
regions, urban residence [78], indicators of poor nutritional status, drinking water source [79],
consumption of raw vegetables [80], and low maternal education. [76, 81] Birth order has also
been identified as a risk factor for H. pylori. A study done in Japan showed that younger siblings
had a higher risk for H. pylori infection than older siblings.[82] We have summarized the risk
factors for H. pylori infection in Table 1.
Table 1: Risk factors for H. pylori infection

Risk factor

Association
with H.
pylori

Reference

Gender

Male (adults)

Increased
risk

Martel et al 2006 [83]

Age

Increasing age
(in children)

Increased
risk

Cullen et al 1993 [84]; Mendall et al 1992
[85]; McCollian et al 1997 [86]

Increasing age
(in adults)

Increased
risk

Parsonnet et al 1992 [87]; Cullen et al
1993 [84];
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Risk factor

Animals

Occupation

Association
with H.
pylori

Reference

increased
risk

Rothenbacher 1998 [88]; Moreira et al,
2004 [81]; Herbarth et al, 2001 [89]

no
association

Webb et al, 1994 [90]; Luzza et al, 1998
[91]; Bode et al, 1998 [92] ; Bazzoli et al,
2001 [93]; Brown et al, 2001 [94]

Sheep

higher risk

Goodman et al, 1996 [95]; Dore et al,
1999 [96]

Endoscopists

increased
risk

Liu et al, 1996 [97]; Lin et al, 1994 [98];
Su et al, 1996 [99]; Mitchell et al, 1999
[5]

no
association

Braden et al, 1997 [100]; Nishikawa et al,
1998[101]

no
association

Lin et al, 1998 [102]; Banatvala et al,
1995 [103]

increased
risk

Matsuda et al, 2005 [104]

endoscopy and
dentistry
nurses

no
association

Lin et al, 1998 [102] ; Banatvala et al,
1995 [103]

direct contact
with patients

Increased
risk

Mastromarino et al, 2005 [105]

increased
risk

Nurgalieva et al, 2002 [22]; Fujimura et
al, 2004 [106]; Rolle-Kampczyk et al,
2004 [107]; Herbarth et al, 2001 [89]

no
association

Yamashita et al, 2001 [108]; Reshetnikov
et al, 2001 [109]

consumption of
fruit and
vegetables

decreased
risk

Goodman et al,1996 [95]; Goodman et
al,1997 [80]; Fontham et al, 1995 [110]

Garlic, ginger

decreased
risk

Jonkers et al [67]

Curcumin

decreased
risk

Foryst-Ludwig et al [68]; Mahaday et al
[69]

Chili peppers

decreased

Jones et al [111]; Lopez Carillo et al [112]

pets at home

Dentists

Water source

Diet
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Risk factor

Association
with H.
pylori

Reference

risk
milk and fat

increased
risk

Guo et al, 2002 [113]

vitamin C

decreased
risk

Jarosz et al. 1998 [114]; Goodman et
al,1997 [80]; Fontham et al, 1995 [110]

increased
risk

Malaty et al, 1998 [115]

Beta-carotines

increased
risk

Goodman et al, 1997 [80]

Meat and fish

increased
risk

Qasim, Webberly, Phukan, Olfasson [116119]

Salt

increased
risk

Kato, Fox, Gamboa [120-123]

no influence

Rothenbacher et al, 1997 [124]; Tindberg
2001b [125]; Leung et al, 2002 [126]

decreased
risk

Rothenbacher et al, 1998 [127]; Bures et
al, 2006 [128]

increased
risk

Reploge et al, 1995 [129]; EUROGAST
study group, 1993 [130]; Malaty et al,
1992 [131]; 1994 [132] ; 1996 [16];
Murray et al, 1997 [133]; Peach et al,
1997 [134]; Hopkins et al, 1993 [135];
Chow et al, 1995 [136]; Buckley et al,
1998 [137]; Rotbenbacher et al, 1998
[138]; Webb et al, 1994 [90]; Souto et
al,1998 [139]; Torres et al, 1998 [140];
Reshetnikov et al, 2003 [30]; Bani-Hani et
al, 2006 [141]

no
association

Teh et al, 1994 [142]; Mendall et al, 1992
[85]; Koch et al, 2005 [143]

increased
risk

Peach et al, 1997 [134]; Goodman et al,
1996 [95]

no
association

Breuer et al, 1996 [144]; Mendall et al,
1992 [85]

Previous
antibiotic
treatment

Socio-economic lower SES
status

Hygiene
practices

poor hygiene
conditions
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Risk factor

Association
with H.
pylori

Reference

sharing a cup
or toothbrush

decreased
risk

Moreira et al, 2004 [81]; AI-Shamahy et
al, 2005 [145]; Bani Hani et al, 2006
[141]; Peach et al, 1997 [134]; Breuer et
al, 1996 [144]; Rodrigues et al, 2004
[146]

raw vegetables

increased
risk

Goodman et al, 1996 [95]; Hopkins et al,
1993 [135]

increased
risk
no
association
increased
risk
increased
risk

Parsonnet, 1995 [147]; Dore et al, 2002
[23]
Tindberg et al, 1999 [148]; WizlaDerambure et al, 2001 [149]
Nessa et al, 2001 [150]; Wallace et al,
2002 [151]
Chow et al, 1995 [136]; Moreira et al,
2004 [81]

increased
risk

Peach et al, 1997 [134]; Kikuchi et al,
2002 [152];
Goodman et al, 1996 [95]; Breuer et al,
1996 [144] Rothenbacher et al, 1997 [153]
and 1998 [138]; Kyriazanos 2001 [154];
Grimm 2003 [155]; Rodrigues et al, 2004
[146]; Bani Hani et al, 2006 [141];
Tindberg, 2001[125]

Attendance at a
day care centre

Institutionalized
persons
Mouth-tomouth contact
Living density

crowded
environment

Educational
higher
status of parents educational
status
Family
H. pylori
positive family
member

Parasites
CagA genotype

no
association
decreased
risk
increased
risk

siblings

increased
risk

Helminthes

Decreased
risk
Increased
risk
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Moreira et al, 2004 [81]; Bani Hani et al,
2006 [141]; Bures et al, 2006 [128]
Ma et al, 1998 [156]; Brenner et al, 1998
[157]; Goodman et al, 2000 [158];
Dominici et al, 1999 [159]; Rothenbacher
et al, 1999 [160]; 2002 [161]; Tindberg,
2001 [125]; Rocha 2003 [162]; Kivi et al,
2005 [163]; Aguemon et al, 2005 [164];
Rowland et al, 2006 [77]
Kikuchi et al, 2002 [152]; Breuer et al,
1996 [144]; Glynn et al, 2002 [165];
Selimoglu et al, 2002 [166]; Farrell et al,
2005 [167]; Kivi et al, 2005 [163]
Fox et al [71, 168, 169]
Azuma, Atherton, Al Marhoon ,Alarcon,
Akimoto [170-176] Evans, Handa, Salih
[177-179]

In summary, possible explanation of the reported low prevalence of peptic ulcer and stomach
cancer with high prevalence of H. pylori in some parts of world such as India, might be related to
difference in diet, environment factors (including helminthes co infection) and prevalence of H.
pylori genotype between different countries. Hence to address this discrepancy we undertook a
cross sectional study in Ecuador and Panama followed by a case control study in India.
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Chapter Two
Study Methods Description
Assessment of H. pylori prevalence and its risk factors among healthy individuals in
Ecuador and Panama
We conducted a cross sectional study in Ecuador and Panama to assess risk factors contributing
to prevalence of H. pylori and its genotypes in healthy individuals. The study was conducted in
Ecuador and Panama from May 2007 to August 2007. All participants were screened for age and
medical history in order to select asymptomatic adult individuals. In this study, asymptomatic
individuals were defined as those who have not had any subjective symptoms of gastric disorders
or have not been diagnosed with any stomach diseases by a medical doctor within the last 6
months. Those individuals who had taken antibiotics within 6 months were excluded. A total of
90 and 75 participants living in Ecuador and Panama, respectively, were enrolled in the study. All
of the participants gave their informed consent. The research protocols were approved by the
ethics committees of the University of South Florida (Tampa, FL), Universidad Central del
Ecuador (Quito, Ecuador), and Instituto Gorgas de Estudios de la Salud (Panama City,
Panama).
Data Collection
Clinical specimens:
The study used stool samples. After signing the informed consent the participants were given an
empty container for stool sample collection. The participants were requested to collect the stool
sample and bring it back to the clinic the next day. The participants were notified of the parasitic
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infections if detected. We carried out the tests in a laboratory in capital of Ecuador. The stool
specimens were delivered to this laboratory at 4ºC and stored at -20ºC until used.
Participant Interview:
After getting the informed consent from the participants, local physicians participating in this
research interviewed the participants using a structured questionnaire. The questionnaire dealt
with issues of food habits, alcohol and cigarette consumption etc. Each interview lasted for on
average of 20 minutes (range: 15 minutes - 45minutes). The interviewer marked the responses in
the survey questionnaire. The form had a unique center and subject ID marked on it.
Detection of Helminthes
Stool samples were emulsified in Protofix, ALPHA TEC, Canada. The identification of
helminthes was made morphologically following the guidelines of the American Society of
Parasitology.
Detection of Helicobacter pylori Antigen
H. pylori antigen (catalase) in stool specimens was detected using a rapid test kit (Testmate Rapid
Pylori Antigen, BD, Tokyo, Japan) by following the manufacturer’s instructions. Briefly, a 20-mg
stool specimen was taken and suspended in the sample dilution buffer (a component of the kit).
One drop of the stool suspension was used for the immunochromatography test. The reaction was
carried out at room temperature for 10 min.
The rapid test kit (Testmate Rapid Pylori Antigen, BD, Tokyo, Japan) uses monoclonal antibodies
that react specifically to native catalase H. pylori antigens.[180, 181] If these antigens are present
in the stool sample, they form immune complexes with the red latex–labeled anti–H. pylori
mouse monoclonal antibodies and migrate by capillary action and then are captured by solid-
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phase anti–H. pylori monoclonal antibodies to form a red test line. Red latex–labeled anti–H.
pylori monoclonal antibodies not forming immune complexes migrate further up to be captured
by solid-phase IgG rabbit polyclonal antibodies forming a red control line. The results were read
in the test window as follows: the result was considered positive if both control and test lines
appeared, negative if only the control line appeared, and uncertain if only the test line appeared.
Since the sensitivity and specificity of the antigen detection method used in this study were high,
bacterial DNA was extracted from H. pylori antigen-positive stool specimens. The DNA
extraction was performed using a QIAamp DNA Stool Mini Kit (Qiagen, Valencia, CA)
according to the manufacturer’s instructions. The bacterial DNA extraction method we used has
been previously used in H. pylori detection with good results. Approximately 1 g of each stool
specimen was suspended in 3.0 mL ASL buffer (a component of the kit). After mixing the
suspension, approximately 1.2 mL of supernatant was used for the extraction. The extracted DNA
was dissolved in a volume of 200 μL AE buffer. All extracted DNA was stored at –20°C until
used. [182]
As a template, 50 ng/μL or a 10-fold diluted solution of the extracted DNA was used for PCR in
consideration of the reducing inhibitors present in stool specimens. For detecting the 16S rRNA of
H. pylori, real-time PCR was performed using TaqMan Universal PCR Master Mix (ABI, Foster
City, CA) according to the method described by Yamazaki and colleagues using the “ABI PRISM
7700 Sequence Detection System’’(Applied Biosystems).[183]
The conditions for real-time PCR were as follows: 95°C for 15 min, followed by 50 cycles
consisting of 95°C for 15 seconds and 60°C for 1 minute.
For genotyping of CagA, nested PCR was adopted. The first-round PCR was performed with 2
primer sets: Forward/Reverse-1 and Forward/Reverse-2.
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The conditions for the first-round PCR were as follows: 95°C for 2 minutes, followed by 40
cycles consisting of 94°C for 15 Seconds, 55°C for 30 Seconds, and 68°C for 1 minute.
The second-round PCR for genotyping of CagA was performed with 1 μL of the first-round PCR
products as a template.
The second-round PCR conditions were as follows: 94°C for 2 minutes, followed by 50 cycles of
98°C for 10 Seconds and 65°C for 2 Seconds.
PCR products of the predicted size were obtained as visualized by 2% agarose gel electrophoresis
with ethidium bromide staining. The specificity of the PCR was determined in several samples by
sequencing of the PCR products. The discriminatory power of the genotyping method was
validated using reference strains. The sensitivity of the method was assessed by a spike test. That
is, serial 10-fold dilutions of H. pylori TK1023 (an East-Asian genotype CagA-positive strain)
suspension in phosphate-buffered saline were added to an H. pylori-negative stool followed by
DNA extraction and PCR. The sensitivity of the method used was 215 ± 14 colony forming unit/g
stool for 16S rRNA by real-time PCR. [182]
Data Entry
Data entry was done in an MS Access database. The database was secured with a password
known to only principal investigator and the co- investigators.
Data Analysis
The association between various risk factors and H. pylori status was analyzed by chi-square test
or Fisher’s exact test. The level of statistical significance was set at P<0.05.
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Assessment of risk factors for peptic ulcer and gastric cancer along with H. pylori infection
in India
We conducted a case control study in India enrolling patients diagnosed with peptic ulcer,
stomach cancer and controls. We assessed the prevalence of H. pylori along with its risk factors
among healthy individuals, and patients diagnosed with peptic ulcer and stomach cancer in Pune,
India. We also followed a cohort of 100 H. pylori positive individuals to assess the effect of
treatment.
Study location: We conducted our study at Pune city in the state of Maharashtra in India at
Deenanath Mangheskar Hospital and Research Center (DMH) between Spring 2008 – Fall 2010.
DMH caters to all strata in the Pune population and is central mutli-speciality hospital. In this
multidisciplinary tertiary level DMH, over 60 research projects are being conducted by young,
highly qualified, abroad-trained, experienced consultants and medical and paramedical men &
women, social workers, clinical psychologists, counsellors and so on. The unique location and
services offered with a strong commitment to clinical research made DMH the hospital of choice
for our study.

Study Methods
Study design
Hospital based case control study. We carried out the case control study with three groups. 1)
Peptic ulcer group: patients diagnosed with peptic ulcer (as defined by hospital record using
international classification of diseases (ICD) 10 codes) 2) Stomach cancer group: patients
diagnosed with gastric cancer (as defined by hospital record using ICD 10 codes) and 3) Controls:
patients obtaining medical care at DMH hospital but not diagnosed with either peptic ulcer or
stomach cancer
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We also followed a cohort of H. pylori positive patients (n =100) during their first visit to DMH.
We enrolled consecutive patients with H. pylori positive patients during their first visit to DMH
until we accrued 100 patients.
We obtained the approval from the institutional review board at University of South Florida and
from the DMH Institutional Ethics Committee (IEC). We revised the questionnaire which was
used in Panama and Ecuador studies by Sasaki and colleagues to suit to the population in Pune,
India.[184] The questionnaire was pilot tested at the DMH in a small focus group enrolling some
affiliated physicians and their patients (n=15). Based on their feedback the questionnaire was
revised at least 5 times (specifically the questions related to food, diet, smoking habits etc.). We
translated the questionnaire into the native Marathi language and back translated it in English
language to assure consistency in terms of content and criterion validity.
The cases were identified via the DMH database using the ICD10 coding. Any patient more than
18 years of age and listed in the DMH database as having diagnosis of either peptic ulcer or
stomach cancer was eligible for enrollment. The cases which were enrolled from the satellite
clinics were enrolled if they were diagnosed (as being either suffering from peptic ulcer or
stomach cancer) by their respective attending physicians. We used SAS software random number
generation code to generate a list of potential eligible patients. We recruited the cases (patients
diagnosed with either peptic ulcer or stomach cancer) at the beginning of the study enrollment
followed by controls. The study personnel contacted the patients in the hospital and requested
them to participate in the study. If the potential participant agreed to participate he / she were
requested to sign the informed consent form. Each participant was given a copy of the signed
informed consent form. The study was explained in details to each potential participant in their
native “Marathi” language by the study personnel.
Data Collection
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We trained 2 local physicians (RAs) to collect data for this project. They were involved in the
project since the revision of the data collection questionnaire. Since they are practicing physicians
in Pune city they had adequate experience and knowledge of local customs and traditions
(especially related to dietary habits etc.). They sent the completed questionnaires every weekend
to principal investigator. We discussed the collected data and resolved any discrepancies by
consensus. Methods for data collection and analysis of stool samples were standardized with all
researchers participating in this study.
H. pylori antigen detection
All the tests were performed by the trained lab technicians at the DMH pathology lab. We
detected the H. pylori antigen from stool specimens using the ImmunoCard STAT HpSA antigen
detection kit. The details of the ImmunoCard STAT HpSA test and the standard operating
procedures that were followed by the DMH pathology laboratory staff are listed below.

ImmunoCard STAT HpSA test
ImmunoCard STAT HpSA is a rapid lateral flow immunoassay that utilizes a monoclonal anti-H.
pylori antibody as the capture and detector antibodies. A diluted patient stool sample is dispensed
into the sample port of the test device and the appearance of a pink-red line in the reading
window next to the letter T after five minutes of incubation at room temperature indicates a
positive result. (Figure 1)
Specimen
Preferred sample types
Only solid, semi-solid or liquid samples were accepted. We rejected samples in transport
media and swab samples or samples mixed with preservatives.
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Interfering substances
The following substances have shown to have no effect on results when present in stool at the
concentrations indicated in the parenthesis.[185]
Tums® Antacid (5 mg/mL), Tagamet® (5 mg/mL), Prilosec® (5 mg/mL), Mylanta® Antacid
(1:20), Pepto-Bismol® (1:20), Barium sulfate (5%), Whole Blood (50%), Leukocytes (50%),
Mucin (3.4%), Stearic acid/palmitic acid (fecal fat) (4%), Hemoglobin (tarry stool)
(12.5%).[185]
Specimen Collection
The specimen were transported in an airtight container and stored at 2º-8º C until tested. The
specimen were tested as soon as possible, but were at times held up to 72 hours at 2º-8ºC prior to
testing. If testing was not performed within this time frame, specimens were frozen immediately
upon receipt and stored frozen (≤ -20ºC) until tested. Specimens were frozen and thawed twice if
required (in case of transportation or other delays in analysis were expected). Stool sample was
thoroughly (regardless of consistency) mixed before testing.
Materials
1. ImmunoCard STAT HpSA Test Devices, in individual foil pouches with a desiccant.
2. Sample Diluent, in a plastic dropper vial.
3. Positive Control, in a plastic dropper vial.
4. 100 µL transfer pipettes.
Preparation and Performance considerations
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Specimens and reagents were brought to room temperature (20º-26º C) before testing. As patient
specimens may contain infectious agents, they were handled and disposed of as potentially
biohazardous. We instructed the lab technicians not to interchange reagents from different kit lot
numbers. We allowed kit components and specimens to reach the room temperature (20º-26º C)
before performing a test, as cold reagents and/or specimens may decrease assay sensitivity.
Reagents took 20-30 minutes to warm following refrigeration. We mixed the stool samples
thoroughly (regardless of consistency) to ensure a representative sample prior to sampling.
Following were the instructions given to the DMH pathology laboratory personnel to ensure
fair and unbiased testing of the stool samples.


Lab technicians were instructed to inspect test devices before removing the foil pouch. They
were also told not to use test devices that had holes in the foil pouch or where the pouch has
not been completely sealed. (False negative reactions may result due to deterioration of the
improperly stored Test Device.)



Similarly, lab technicians were instructed not to use the sample diluent or positive control if
turbid. Turbidity may be a sign of microbial contamination. The positive control was handled
as potentially infectious even though it contains inactivated H. pylori.



Lab technicians were instructed to hold reagent vials vertically when dispensing drops to
ensure consistent drop size and delivery.



Lab technicians were requested to not deviate from the method described here or falsely
positive or falsely negative results may occur.



Lab technicians were instructed to thoroughly read the test instructions before performing any
testing and to not use a device if its pouch was punctured prior to use.



Lab technicians were made aware that at times particulate matter may initially interfere with
sample flow. In cases where the test device does not readily absorb the diluted specimen,
gently touch the bottom of the sample port with an applicator stick, moving the stool solid
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particle that might prevent the absorption. Alternatively, a new aliquot of the sample can be
withdrawn from the diluent and retested.


Lab technicians were instructed to store kit refrigerated at 2º to 8º C and return the test kit to
the refrigerator promptly after each use. Lab technicians were instructed to not freeze the kit.
Quality control
The reactivity of ImmunoCard STAT test devices was verified upon receipt using the
external positive and negative control reagents provided in the kit. We evaluated the test in
the following manner.
Internal controls
Internal controls are contained within the test device and therefore were evaluated with each
test.
1.

A colored band appearing at the control line served as a positive control and

indicated that the test has been performed correctly, that sample was added, that it flowed
properly, and that the test reagents were active at the time of use.
2.

A clear background around the control or test lines served as a negative control.

A background that obscures the reading of results invalidates the test and can be an
indication of reagent deterioration, inappropriate sample or improper test performance.
External controls: The reactivity of ImmunoCard STAT HpSA Test Devices were
verified upon opening each new kit using the external Positive and Negative Control
reagents provided in the kit. Each operator was strictly advised to test a positive and
negative control at least once with each 20-test kit.
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Procedure
(Each lab technician was given a print out of the following standard operating procedure for
performing this test.)
A.

Test

1. Bring all test devices, reagents and samples to room temperature (20º-26º C) before testing.
2. Use 1 ImmunoCard STAT Test Device for each patient sample.
3. Remove the ImmunoCard STAT Test Device from its foil pouch. The Test Device is
marked to indicate where test and control lines will appear. The round window marked
with an arrow is the test window where sample is added.
4. Label the device with the patient’s name. Prepare the specimen according to the
instructions in the specimen collection and preparation section above.
5. Hold the diluted specimen vial upright and tap the bottom gently on the countertop before
proceeding.
6. Cover the top of the diluted sample vial with absorbent paper to avoid splatter.
7. Break off the red tip on the outside of the red cap. (Do not break off the white applicator
stick on the inside of the cap.)
8. Hold the vial upside down and dispense 4 drops of diluted sample into the round window
(at arrow) of the Test Device. Do not touch the tip of the vial to the Test Device.
9. Set a timer and incubate the test at 20º-26º C for 5 minutes.
10. At the end of 5 minutes, read the results within 1 minute. See the Interpretation of results
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section below for a description of positive and negative test results.
B.

Alternate Test Procedure with Simple Sample

Simple sample is an alternate sampling unit that can be used in place of the Sample Diluent
vial provided with ImmuonoCard STAT HpSA test kit.
1. Bring all test devices and Simple Sample dilution vials to room temperature (20º-26º C)
before testing.
2. Use 1 ImmunoCard STAT Test Device for each patient sample.
3. Remove the ImmunoCard STAT Test Device from its foil pouch. The Test Device is
marked to indicate where test and control lines will appear. The round window marked with
an arrow is the test window where sample is added.
4. Label the device with the patient’s name. Prepare the specimen according to the
instructions in the Simple Sample package insert.
5. Mix specimen by inverting the Simple Sample several times. Remove the translucent
screw cap from the tip of the Simple Sample.
6. Hold the Simple Sample vial upside down and dispense 4 drops of diluted sample into the
round window (at arrow) of the Test Device. Do not touch the tip of the vial to the Test
Device.
7. Set a timer and incubate the test at 20º-26º C for 5 minutes.
8. At the end of 5 minutes, read the results within 1 minute. See the interpretation of results
section below for a description of positive and negative test results.
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C.

Controls

Positive and Negative Controls are designed to show all reagents are reactive, specific, and
capable of producing the expected results.
a. Bring all control reagents to 20º-26ºC before testing.
b. Use 1 ImmunoCard STAT Test Device each for a Positive and Negative Control.
Label each device with the control to be tested.
c. Hold reagent vials upside down to dispense reagents.
d. Add 4 drops of the Positive Control to the test window (at arrow) of 1 device. Do not
allow the tip of the vial to touch the sample port.
e. Break off the red tip on the outside of the red cap of an unused vial of Sample
Diluent.
f.

Dispense 4 drops of the Sample Diluent to the test window (at arrow) of another Test
Device.

g. Set a timer and incubate the tests at 20º-26º C for 5 minutes.
h. After 5 minutes, read the results within 1 minute of test completion.
Interpretation of results
Negative test result
Only one BLUE colour band (Control Line) appears across the central window of the
device close to the letter “C”. (H. pylori antigens are absent or below the level of
detection.) No other bands should be seen.
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Positive test result
In addition to the BLUE band (Control Line), a distinguishable PINK-RED band (Test
Line) also appears across the central window of the device close to the letter “T”. The
intensity of the band will vary depending on the antigen concentration in the specimen.
Any pink-red line, even very weak, must be considered as a positive result. (A positive
test line indicates that H. pylori antigens are in the specimen.) The background should
not interfere with reading the test. (Figure1)
Invalid test results
1.

The BLUE band (Control Line) is absent, with or without a visually

detectable PINK-RED band (Test Line),
2.

A PINK-RED band appears at the letter “T” in the window after six

minutes, or there is a line at this position of another colour other than pink-red,
3.

No Control Line band appears close to the letter “C”. (The test is invalid

since a shift in or absence of the control line indicates that the test procedure was
performed improperly or that deterioration of the reagents has occurred.)
If any test is difficult to interpret, the test should be repeated with the same sample to
eliminate the potential for error. Obtain a new sample and retest when the original sample
repeatedly produces unreadable results.
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Reporting of results
Negative for H. pylori
Report test result as: “H. pylori antigen is absent or below the level of detection.”
Positive for H. pylori
Report test result as: “H. pylori antigen detected.”
Expected values
Studies on the epidemiology of H. pylori have shown that this organism is present worldwide.
Gastritis caused by H. pylori has been shown to correlate with age, ethnic background, family
size and socioeconomic class. The prevalence of H. pylori infection in a given population
can vary from 20% to 90%. In patients diagnosed with duodenal ulcers, however, it has been
shown in every age group to be approximately 80%. Currently recommended eradication
treatments have an efficacy rate between 75% and 90%. The ImmunoCard STAT HpSA test
detects the presence of H. pylori antigens in human stool.
Limitations of the test
1. The test is qualitative and no quantitative interpretation should be made with respect to
the intensity of the positive line when reporting the result.
2. Test results are to be used in conjunction with information available from the patient
clinical evaluation and other diagnostic procedures.
3. Failure to add sufficient stool to the Specimen Diluent may result in a falsely negative
test result. Addition of too much stool may result in invalid test results due to the inhibition
of proper sample flow.
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4. Over incubation of tests may lead to false-positive test results. Incubating tests at
reduced temperatures or times may lead to falsely negative results.
5. Performance characteristics have not been established for watery diarrheal stools.
Watery stools composed mainly of fluid with little or no solid matter may give false negative
test results.

Figure 1 ImmunoCard STAT HpSA test results
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Sample Size Calculations
We based our sample size calculations assuming following parameters: alpha error = 0.5, power
(beta error) = 0.90, Effect size (odds ratio) = 2.1, proportion of controls with the exposure = 0.40
(H. pylori), proportion of cases with the exposure (H. pylori) = 0.50. The required sample size
was 314 (157 cases and 157 controls). Based on the current literature and research conducted in
India the average odds ratio addressing the relationship of H. pylori between peptic ulcer cases
and controls was 4.2. We have utilized a much conservative OR in our sample size calculations.
We created an MS access database for entering the data. The database was pilot tested in India
and then revised to accommodate the suggestions by the RAs.
Data Analysis
The association between each potential risk factor and the outcome (H. pylori status, chronic
gastric disease status, disease status) was measured using logistic regression models containing
only the risk factors of interest. All risk factors associated with (H. pylori status, chronic gastric
disease status, disease status) (at p < .10) were then entered into a multivariable logistic
regression with backward elimination (p < .05 to retain) to select the final set of independent risk
factors. The same multivariable model was chosen using a forward stepwise selection with an
entry level p = .10 and a stay level p = .05. The multiple logistic regression model fit was
determined by the Hosmer–Lemeshow test statistic. A model was considered a fit for the data if
the Hosmer–Lemeshow statistics was with p value > .05. Continuous variables were checked in
the models for linearity in the logic, using the method of fractional polynomials. We also check
all the models for the presence of effect modification due to age and gender. Statistical analyses
were conducted using SAS 9.1.3 (SAS Institute, Cary, NC, USA) and STATA 9.0 (STATA
Corporation, College Station, TX, USA). All p-values are two-sided and a p < .05 was considered
statistically significant.
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Chapter Three
Assessment of H. pylori prevalence and its risk factors among healthy individuals in
Ecuador and Panama
Background
One of the most important virulence factors of H. pylori is CagA, which is located in the
pathogenicity island region. [184] CagA is further classified into 2 major types, East-Asian type
and Western type. The East-Asian type CagA is considered to be more virulent than the Western
type by virtue of its more potent stimulation of host signal transduction pathways. [184] [186]
Hence, many researchers have studied CagA genotype extensively from stomach biopsies of
individuals suffering from gastric ailments. [184] [187, 188] However, since it is tedious to
collect gastric biopsy samples from asymptomatic individuals, the genotype of the virulence
factors of H. pylori isolated from asymptomatic people have been insufficiently analyzed, both
qualitatively and quantitatively. [184] Analysis of H. pylori infection in asymptomatic people in
areas with different prevalence of stomach cancer may provide important information regarding
the possible factors contributing to the development of stomach cancer. [184] So, to assess the
risk factor contributing to prevalence of H. pylori and its genotypes in healthy individuals in
Ecuador and Panama we undertook a cross sectional study with following specific aims:
1) To determine the prevalence of H. pylori among healthy individuals living in Ecuador and
Panama 2) To determine the prevalence of CagA positive H. pylori infection in healthy
individuals in Ecuador and Panama and 3) To determine various risk factors for prevalence of H.
pylori infection.
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Methods
The study was conducted in Ecuador and Panama from May 2007 to August 2007. All
participants were screened for age and medical history in order to select asymptomatic adult
individuals. Asymptomatic individuals were defined as those who have not had any subjective
symptoms of gastric disorders or have not been diagnosed with any stomach diseases by a
medical doctor within the last 6 months. Those individuals who had taken antibiotics within 6
months were excluded. A total of 90 and 75 participants living in Ecuador and Panama,
respectively, were enrolled in the study. All of the participants gave their informed consent. The
research protocols were approved by the ethics committees of the University of South Florida
(Tampa, FL), Universidad Central del Ecuador (Quito, Ecuador), and Gorgas de Estudios de la
Salud (Panama City, Panama).
We collected data on risk factors for H. pylori infection in one on one interview conducted by a
bilingual (English-Spanish) interviewer using a structured questionnaire. H. pylori antigen
(catalase) in stool specimens was detected using Testmate Rapid Pylori Antigen kit (BD, Tokyo,
Japan) by following the manufacturer’s instructions. Briefly, a 20-mg stool specimen was taken
and suspended in the sample dilution buffer. One drop of the stool suspension was utilized for the
immunochromatography test. The reaction was carried out at room temperature for 10 min. H.
pylori virulence factor cagA was genotyped by polymerase chain reaction. The identification of
helminth was made morphologically following the guidelines of the American Society of
Parasitology. The association between various risk factors and H. pylori status was analyzed by
chi-square test or Fisher’s exact test. Statistical significance was set at P<0.05.
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Results
The demographic characteristics of 90 participants from Ecuador are listed in Table 2. There were
68 (76%) study participants between 30 to 55 years of age. The number of females and males in
the study were approximately equal (48 and 42 respectively). The percentage of participants who
have primary or secondary school education was 69, while only 23% of the sample had university
level education and 8% had a diploma. Majority (77%) of the subject’s ethnicity was Mestizo.
Table 2 Demographic characteristic of the participants in Ecuador (n =90).
Characteristics
Age group
30-55 years
> 55 years
Gender
Female
Male
Education
Primary
High School
University
Other (diploma)
Ethnicity
Mestizo
African descent
Spanish descent
Indian descent
Length of stay at current residence
0.5-20 years
21-40 years
>40 years

N (%)
68 (76)
22 (24)
48 (53)
42 (47)
36 (44)
21 (25)
21 (23)
12 (8)
70 (77)
6 (7)
7 (8)
7 (8)
53 (59)
27 (30)
10 (11)

The demographic characteristics of 75 participants from Panama are presented in Table 3. There
were 34 (45%) study participants between 20 to 55 years of age. The number of females (37 %(
28 /75)) were less compared to males (63 %( 47/75)). The percentage of participants who have
primary or high school education was 84 (63/75), while only 16% (12/75) were uneducated.
Majority (46% (32/75)) of the subject’s ethnicity was Spanish decent.
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Table 3 Demographic characteristic of the participants in Panama (n= 75)
Characteristics
Age group
20-55 years
> 55 years
Gender
Female
Male
Education
None
Primary / High School
Ethnicity
Mestizo
African descent
Spanish descent
Indian descent
Length of stay at current residence
0.5-20 years
21-40 years
>40 years

N (%)
34 (45)
41 (55)
28 (37)
47 (63)
12 (16)
63 (84)
18 (26)
3 (4)
32 (46)
17 (24)
8 (11)
15 (20)
52 (69)

The frequency distribution of participant characteristics by three study sites in Ecuador in listed in
Table 4. A total of 71% (65/90) of subjects were infected with H. pylori. These 65 subjects were
evenly distributed over the three study regions. One third of our study participants had history of
chronic gastric disease. We did not confirm this by examining the subject for diagnosis of chronic
gastric disease in our study. The prevalence of intestinal parasitic infection and the drugs used for
its treatment along with drugs used for general parasitic infection was similar in three study
regions. We did not find any regional differences in the prevalence of protozoa infestation. But
malaria was significantly associated with different regions (P-Value=0.00). Compared to cases of
malaria in highlands of Quito, there were significantly higher number of cases in subtropical area
of La Concordia and tropical Atacames.
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Table 4: Frequency of study variables by regions in Ecuador
Participant
characteristics
H. pylori
Positive
Negative
Gastric disease
Yes
No
Intestinal Parasite
Yes
No
Malaria
Yes
No
Anti parasitic drug use
Yes
No
Intestinal parasite drug
use
Yes
No
Protozoa infestation
Yes
No

Quito
N (%)

La Concordia
N (%)

Atacames
N (%)

P-Value

20 (31)
9 (36)

23 (35)
10 (40)

22 (34)
6 (24)

0.66

12 (39)
17 (29)

11 (36)
22 (37)

8 (25)
20 (34)

0.59

19 (34)
10 (30)

20 (35)
13 (38)

17 (31)
11 (32)

0.92

3 (7)
26 (59)

26 (56)
7 (16)

17 (37)
11 (25)

0.00

22 (30)
7 (41)

29 (40)
4 (23)

22 (30)
6 (36)

0.49

11 (35)
18 (30)

8 (26)
25 (42)

12 (39)
16 (28)

0.27

9 (24)
20 (38)

17 (45)
16 (31)

12 (31)
16 (31)

0.26

The relationship between selected participant characteristics and their H. pylori status in Ecuador
are given in Table 5. Demographic characteristics such as gender, length of stay at current
residence and age were not associated with H. pylori status. However, overall educational
attainment was significantly associated with H. pylori status (P-Value=0.03). Participants who
had lower education were more likely to have H. pylori infection compared to participants who
had higher education. Study participant’s current tobacco use and the age at which they started
smoking were not associated with H. pylori (P-Value=1.00 and 0.15 respectively). Amount of
whiskey and beer consumption per day were not associated with H. pylori status (P-Value=0.17
and 0.58). Prevalence of gastric disease was not associated with H. pylori status (P-Value=0.32).
In this study, the amount of chili peppers consumed were not associated with H. pylori (PValue=0.34). Furthermore, anti-parasitic drug use and protozoa infestation were not associated
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with H. pylori status (P-Value=1.00 and 0.81 respectively).
Table 5: Relationship between participant characteristics and H. pylori in Ecuador

Participant
characteristics
Gender
Female
Male
Education
Primary School
High School
University
Other
Smoking Age
<20 years
21-35 years
>36 years
Alcohol amount
(whiskey)
<= 50 mL / day
> 50 mL / day
Chili peppers amount
<= 1.5 chili peppers/day
> 1.5 chili peppers/day
Current Tobacco use
Yes
No
Beers per day
<= 1 can / bottle
2-4 cans / bottles
>= 5 cans / bottles
Gastric disease
Yes
No
Anti-parasitic drug use
Yes
No
Protozoa infestation
Yes
No

H. pylori
Present N
(%)

Absent N
(%)

P-Value

33 (69)
32 (76)

15 (31)
10 (24)

0.48

22 (61)
19 (91)
13 (62)
11 (92)

14 (39)
2 (9)
8 (38)
1 (8)

0.03

24 (80)
4 (44)
37 (72)

6 (20)
5 (64)
14 (28)

0.15

51 (76)
14 (60)

16 (24)
9 (40)

0.17

36 (68)
29 (78)

17 (32)
8 (22)

0.34

30 (73)
35 (71)

11 (27)
14 (29)

1.00

39 (70)
16 (80)
10 (66)

16 (30)
4 (20)
5 (34)

0.58

20 (65)
45 (76)

11 (35)
14 (24)

0.32

53 (73)
12 (71)

20 (27)
5 (29)

1.00

28 (74)
37 (71)

10 (26)
15 (29)

0.81

The relationship between selected participant characteristics and their H. pylori status in Panama
are presented in Table 6. Demographic characteristics such as length of stay at current residence
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and age were not associated with H. pylori status. However, male participants were more likely to
have H. pylori infection compared to female participants (P-Value=0.05). Study participant’s
smoking status and the age at which they started smoking were not associated with H. pylori (PValue=0.10). However, alcohol amount was associated with H. pylori status. Participants who
were consuming more than 50ml of alcohol per day were more likely to have H. pylori infection
compared to participants consuming 50ml or less alcohol per day. (P-Value=0.02). Chronic
gastric disease was not associated with H. pylori (P-Value=0.40). The amount of chili peppers
consumed were not associated with H. pylori (P-Value= 0.79). Furthermore, anti-parasitic drug
use and protozoa infestation were not associated with H. pylori status (P-Value=0.23 and 1.00
respectively).
Table 6: Relationship between participant characteristics and H. pylori in Panama

Participant characteristics

Gender
Female
Male
Education
None
Primary
High School / Technical
Smoking
Yes
No
Alcohol amount
<= 50 mL / day
> 50 mL / day
Chili peppers amount
<= 1.5 chili peppers/day
> 1.5 chili peppers/day
Chronic gastric disease
Yes
No
Anti-parasitic drug use
Yes
No
Protozoa infestation
Yes
No

H. pylori
Present N (%) Absent N (%)

P-Value

11 (39)
30 (64)

17 (61)
17 (36)

0.05

8 (67)
31 (55)
2 (29)

4 (33)
25 (45)
5 (71)

0.26

20 (67)
21 (47)

10 (33)
24 (53)

0.10

13 (39)
28 (67)

20 (61)
14 (33)

0.02

13 (59)
28 (53)

9 (41)
25 (47)

0.79

7 (44)
34 (58)

9 (56)
25 (42)

0.40

25 (56)
14 (54)

20 (44)
12 (46)

0.23

2 (50)
39 (55)

2 (50)
32 (45)

1.00
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The relationship between participant characteristics and chronic gastric disease in Ecuador are
presented in Table 7. Education and gastric disease were not associated with each other (PValue=0.13). The p-value suggests that education has a weak association with chronic gastric
disease. Participants who had lower education were found to have chronic gastric disease
compared to participants who had higher education. Antiparasitic drug use for intestinal parasites
was associated with having chronic gastric disease (P-Value=0.06). Individuals having history of
antiparasitic drugs use for intestinal parasites were found to have chronic gastric disease.
Hypertension was significantly associated with having chronic gastric disease (P-Value=0.01).
Hypertensive individuals seemed to have chronic gastric disease. Individuals who reported
current medication use were also found to have chronic gastric disease (P-Value=0.08).
Table: 7 Relationship between participant characteristics and chronic gastric disease in Ecuador
Participant characteristics
Center
Quito
La Concordia
Atacames
Gender
Female
Male
Education
Primary School
High School
University
Other
First Food Choice
Vegetarian
Non-Vegetarian
Intestinal anti-parasitic drug
use
Yes
No
Hypertension
Yes
No
Current Medication use
Yes
No

Chronic gastric disease
Present N (%) Absent N (%)

P-Value

12 (41)
11 (33)
8 (29)

17 (59)
22 (67)
20 (71)

0.59

19 (40)
12 (29)

29 (60)
30 (71)

0.37

14 (38)
9 (43)
5 (25)
0 (0)

23 (62)
12 (57)
15 (75)
7 (100)

0.13

15 (45)
16 (28)

18 (55)
41 (72)

0.11

15 (48)
16 (27)

16 (52)
43 (73)

0.06

9 (64)
22 (29)

5 (36)
54 (71)

0.01

13 (48)
17 (28)

14 (52)
44 (72)

0.08
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Participant characteristics
Beers per day
<= 1 can / bottle
2-4 cans / bottles
>= 5 cans / bottles
Alcohol consumption
<= 1 drink/month
> 1 drinks/month
Everyday

Chronic gastric disease
Present N (%) Absent N (%)

P-Value

24 (43)
4 (20)
3 (21)

22 (57)
16 (80)
11 (79)

0.11

27 (38)
3 (17)
1 (50)

43 (62)
15 (83)
1 (50)

0.15

The relationship between selected participant characteristics and chronic gastric disease in
Panama is listed in Table 8. Education, gender and ethnicity were not associated with chronic
gastric disease. Similarly, alcohol amount and amount of chili peppers consumed were not
associated with chronic gastric disease. However, smoking status was associated with chronic
gastric disease (P-Value=0.04). Antiparasitic drug use and protozoa infestation were not
associated with chronic gastric disease.
Table: 8 Relationship between participant characteristics and chronic gastric disease in Panama

Participant
characteristics
Gender
Female
Male
Education
None
Primary
High School / Technical
Ethnicity
Mestizo
African descent
Spanish descent
Indian descent
Smoking
Yes
No
Alcohol amount
<= 50 mL / day
> 50 mL / day

Chronic gastric disease
Present N (%) Absent N (%)

P-Value

4 (14)
12 (25)

24 (86)
35 (75)

0.38

4 (33)
10 (18)
2 (29)

8 (67)
46 (82)
5 (71)

0.43

0 (0)
1 (33)
8 (25)
6 (35)

18 (100)
2 (67)
24 (75)
11 (65)

0.06

10 (33)
6 (13)

20 (67)
39 (87)

0.04

5 (15)
11 (26)

28 (85)
31 (74)

0.27
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Participant
characteristics
Chili peppers amount
<= 1.5 chili peppers/day
> 1.5 chili peppers/day
Anti-parasitic drug use
Yes
No
Protozoa infestation
Yes
No

Chronic gastric disease
Present N (%) Absent N (%)

P-Value

5 (23)
11 (21)

17 (73)
42 (79)

1.00

25 (56)
14 (54)

20 (44)
12 (46)

0.23

10 (22)
5 (19)

35 (73)
21 (81)

1.00

Assessment of H. pylori antigen in the stool specimens obtained from participants revealed an H.
pylori infection rate of 72% in Ecuador, and that this positive rate was significantly higher than
the rate detected in Panama (54%) (Figure 2).
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Ecuador (N = 90)

Panama (N= 74)

Number of positive / Number
tested (%)

Number of positive / Number
tested (%)

H pylori antigen test:
65/90 (72%)

P value = 0.01

H pylori antigen test:
40/74 (54%)

H pylori gene detection:
61/65 (94%)

P value = 0.29

H pylori gene detection:
35/40 (87%)

cag A status:
28/61 (46%)

P value = 0.01

cag A status:
7/35 (20%)

East Asian cagA status:
25/28 (89%)

P value = 1.00

East Asian cagA status:
7/7 (100%)

Figure 2 H. pylori genotype assessment
Bacterial DNA was extracted from H. pylori antigen-positive stool specimens and the extracted
DNA was subjected to PCR for the detection of H. pylori genes. The H. pylori 16S rRNA gene
was detected by real-time PCR for confirmation of the existence of H. pylori DNA in the
extracted DNA. As shown in Figure 1, H. pylori genes were detected in 94% of H. pylori
antigen-positive Ecuador specimens and in 87% of the Panama specimens.[182]
The CagA gene was detected in 46% and 20% of the H. pylori DNA-positive specimens from
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Ecuador and Panama, respectively, and this difference was demonstrated to be statistically
significant (Figure 1). Furthermore, analysis of the CagA genotype revealed that the East-Asian
type was predominant in both countries (89% in Ecuador and 100% in Panama) (Figure 1).[182]
Discussion:
This was the first study to document the prevalence of H. pylori among healthy individuals in
Ecuador and Panama. Previously, it was reported that the prevalence of H. pylori infection in
dyspeptic patients in Ecuador was 89.5% [189] and 79.6% to 82.9% in patients with chronic
dyspepsia, gastric or duodenal ulcer, gastritis, or gastric cancer in Panama. [190-192] The results
obtained in the present study are slightly lower than the published data for patients with chronic
gastric disease in Ecuador and Panama. However, the infection rates in our study are higher than
those in Western countries (32.7% in the United States, 25.4% in France, and 39.2% in
Germany), which have a lower incidence of gastric cancer. [66] The reasons for the high H.
pylori infection rates in asymptomatic people in both Ecuador and Panama are not clear. It is
speculated that the poor public health conditions in both countries may be a contributory factor in
the facilitating transmission of H. pylori.
We hypothesize that certain prevalent food habits such as pre mastication of food by parents
while feeding infants (person to person transmission via saliva) [193], consumption of restaurant
food and possible contaminated water consumption (feco-oral transmission) might explain the
high prevalence of H. pylori in Ecuador and Panama. In Ecuador and Panama the drinking water
is chlorinated but the wastewater is not treated and is used for irrigation. Some researchers have
recently shown that H. pylori can thrive in a non culturable coccoid form in biofilms even after
chlorination. [194-197] Hence H. pylori may be able to tolerate disinfectants in distribution
systems and, therefore, may be transmitted by a waterborne route.
The detection of CagA in extracted DNA revealed that 46% of H. pylori DNA-positive samples
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were CagA-positive in Ecuador, but that only 20% of similar samples were CagA-positive in
Panama. Thus, a significant number (28%) of asymptomatic people in Ecuador are infected with
the more pathogenic East-Asian genotype CagA-positive H. pylori. We hypothesize that this
might be due to the racial differences between people from Ecuador and Panama. The high
incidence rate of gastric cancer in Ecuador (24 per 100,000) compared to Panama (11.6 per
100,000) can be attributed to these differences in CagA positive H. pylori prevalence.[198]
The results obtained in the present study indicated that the methodology used is suitable for
assessing the status of H. pylori infection in asymptomatic people. In addition, these results suggested that the prevalence of H. pylori infection and/or the occurrence of CagA in the H. pylori
detected in asymptomatic people may be related to the risk of stomach cancer.
Most of the risk factors of interest were not significantly associated with H. pylori and chronic
gastric disease. Our study concluded that gender was not associated with either H. pylori or
history of gastric disease for a long duration. This finding is consistent with studies done in India
and Northwest region of Ethiopia. [199-201] Education attainment was weakly associated with
chronic gastric disease. However the contingency table analysis suggested that chronic gastric
disease was more prevalent among participants having primary school education than participants
having secondary school education and higher. In case of H. pylori prevalence; primary educated
individuals had fewer than expected H. pylori cases than university level education. But at the
same time we found that secondary level educated individuals had higher than expected H. pylori
prevalence. This finding is not consistent with studies done in Saudi Arabia and Brazil where
lower education was associated with high prevalence of H. pylori. [81, 202-207]
So far in many of the studies published we found that H. pylori incidence was increasing with
age. In our study age not associated with H. pylori. (P value = 1.00) Our finding is not consistent
with other studies probably due to the small sample size (n = 90) Owing to our inclusion criteria
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the youngest participant in our study was 39 years old. After categorizing the participant’s age
into only two groups we did not find any association with H. pylori.
Tobacco and alcohol use was found to be associated with H. pylori in many of the studies
published so far. [74, 130, 208-210] In our study the current tobacco use, age at which the
participant’s started to smoke cigarettes and alcohol consumption (whiskey, beer and home-made
alcohol) was not associated with H. pylori status.
Dietary choices such as being vegetarian and eating chili peppers were not associated with H.
pylori status (P value ≥ 0.10). Anti-parasitic drug use and protozoa infestation were not associated
with H. pylori status.
Entamoeba coli was the most prevalent infection (n=20) followed by Entomeba Histolytica (n =
13). Eight study participants were found to have Endolimax nana infection where as only six
study participants were found infected with Blastocistis Hominis.
In this cross sectional study we used prevalence of chronic gastric disease as a surrogate measure
of gastric pathology in general. In this study we tried to shed more light on the relationship
between gastric disease and risk factors such as education, spicy food consumption, consumption
of high temperature food, intestinal parasite drug use, and hypertension. These risk factors were
associated with having chronic gastric disease.
Our study had some limitations. This was a cross sectional study. Hence we did not expect to
prove cause – effect relationship between various risk factors of H. pylori and its prevalence.
Owing to the financial constraints we recruited ninety participants from three areas of Ecuador.
During the data analysis; as evident from the contingency tables overview this sample of ninety
individuals proved to be small as most of the variables that we assessed were having cell size less
than five. Overall the power of the Fisher exact test used to test the association between risk
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factors and H. pylori was poor (power = 0.20). We collected information regarding history of
chronic gastric disease. In our data analysis we have used chronic gastric disease as an indicator
variable for gastric pathology. One of the study aims was to elucidate the relationship between
helminth and H. pylori co-infection. We collected the stool specimens from all the study
participants and we analyzed it for presence of helminthes. Only one study participant was
diagnosed to have a helminth infection (Strongloydes stercolis). Our study participants were from
a lower / moderate socio-economic status; we believe that the data we have is an indicator of the
success of the mass de-worming campaign implemented by the government of Ecuador.
Based on above mentioned limitations and findings we revised the data collection instrument and
study design to conduct a hospital based case control study in India.
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Chapter Four
Assessment of risk factors for peptic ulcer and gastric cancer along with Helicobacter pylori
infection in India
Background
It is estimated that the gastric pathogen Helicobacter pylori (H. pylori), first isolated in 1982 by
Warren and Marshall, infects more than 50% of the world’s population. [130, 211-214] The
infection is usually acquired in childhood, with low socioeconomic status being associated with a
high prevalence of infection. There is variation in the prevalence of H. pylori among various
countries in the world. [38, 128, 130, 211, 214-217] Previous studies from India have reported a
high, at times as high as 80% prevalence of H. pylori in India. [66] Peptic ulcer disease is
frequent in India but there is paucity of data on its prevalence.[41, 218] The prevalence of peptic
ulcer is noted to be on average around 8.0 per 100,000 in India. [41] The age adjusted incidence
rate of gastric cancer in urban registries in India is reported in the range of 3.0 per 100,000 which
is on the lower side among those reported worldwide (14 per 100,000). [219] Previous Indian
studies on the prevalence of peptic ulcer were not community based and may have been subject to
selection bias. Indeed, some researchers have noted the association between H. pylori infection
and peptic ulcer in India but at times no association between stomach cancer and H. pylori
infection. [31, 220-224] However, these studies are criticized to have small sample size and
inadequate methodological details such as inadequate description of sample size calculations,
case definitions etc. [35, 225-227] Nonetheless, no studies have been conducted in Western India
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enrolling adequate number of patients and having sound methodological quality to assess the
relationship between peptic ulcer and H. pylori and their various risk factors. Indeed, some
researchers have noted that apart from the virulent genotype of H. pylori environmental and
dietary factors influence the outcome of disease. [117, 221, 228, 229] However, these risk factors
for prevalence of H. pylori especially the environmental and dietary factors in Indian context
have received minimal attention.
Hence to address these issues we conducted a case control study in Pune, Maharashtra, India with
following specific aim. 1) To determine various risk factors for peptic ulcer, stomach cancer and
prevalence of H. pylori infection in Pune, India.
Methods
We conducted our study at Pune city in the state of Maharashtra in India at Deenanath
Mangheskar Hospital and Research Center (DMH) between Spring 2008 – Fall 2010. Our
hospital based case control study had three groups: 1) peptic ulcer patients 2) stomach cancer
patients 3) controls. The peptic ulcer and stomach cancer cases were identified via the DMH
database using the ICD10 coding. Any patient more than 18 years of age and listed in the DMH
database as having diagnosis of either peptic ulcer or stomach cancer was eligible for enrollment.
We also followed a cohort of H. pylori positive patients (n =100) during their first visit to DMH.
We enrolled consecutive patients with H. pylori positive patients during their first visit to DMH
until we accrued 100 patients.
We collected data on risk factors for H. pylori infection in one on one participant interview. All
interviews were conducted by the bilingual (English – Marathi) speaking native study research
associates (RA). H. pylori antigen in stool specimens was detected using ImmunoCard STAT
HpSA antigen detection kit by following the manufacturer’s instructions. (Meridian Diagnostics,
Inc, USA). Briefly, a small portion (5-6 mm diameter) of stool specimen was transferred into the
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sample diluent vial using the applicator stick, vortexed for 15 s, and then 4 drops were dispensed
into the round window at the lower end of the device. The results were read 5 min later.
We based our sample size calculations assuming following parameters: alpha error = 0.5, power
(beta error) = 0.90, Effect size (odds ratio) = 2.1, proportion of controls with the exposure = 0.40
(H. pylori), proportion of cases with the exposure (H. pylori) = 0.50). The association between
each potential risk factor and the outcome (H. pylori status, chronic gastric disease status, disease
status) was measured using logistic regression models containing only the risk factors of interest.
All p-values are two-sided and a p < .05 was considered statistically significant. We obtained the
approval for this project from the institutional review board at University of South Florida and
from the DMH ethics committee.

Results:
We contacted a total of 491 potential participants. We were able to enroll 190 patients diagnosed
with peptic ulcer and only 35 patients diagnosed with stomach cancer. We then were able to
enroll 125 controls in our study. (Figure 3)
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Total controls screened
for enrollment in the study
N = 195

Total cases screened for
enrollment in the study
N = 296

Total cases NOT eligible
for enrollment in the study
N = 35

Total controls NOT
eligible for enrollment in
the study
N = 25

Total cases who didn’t
submit the stool sample
N = 36

Total controls who didn’t
submit the stool sample
N = 45

Total controls enrolled in
the study
N = 125

Total cases enrolled in
the study
N = 225

Total peptic ulcer cases
enrolled in the study
N = 190

Total stomach cancer
cases enrolled in the
study
N = 35

Figure 3 Study participant recruitment flow chart
The median age of the enrolled participants was 56 years (range: 18 – 83 years). Fifty three
percent (187/350) of participants were females while 47% (163/350) were males. Forty percent
(139 /350) of participants had primary education while 32% (111/350) had completed high
school. Only 29% (100/350) of participants had university level education. (Table 9)
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Table 9 Demographic characteristics of study participants Pune, India
Characteristics
Disease
Controls
Peptic ulcer
Stomach cancer
Median age (Range)
Gender
Female
Male
Education
Primary School
High School
University

N (%)
125 (36)
190 (54)
35 (10)
56 years (range:18-83)
187 (53)
163 (47)
139 (40)
111 (32)
100 (29)

In the initial univariate analysis, demographic characteristics such as gender (P-Value=0.74),
education (P-Value=0.12), age were not associated with H. pylori status. Study participant’s
disease status (having peptic ulcer versus not having any gastric ailment) was associated with H.
pylori (P-Value=0.00). Study participant’s current tobacco use was associated with H. pylori (PValue=0.01). Participants’ consumption of snacks while drinking alcohol was not associated with
H. pylori status (P-Value=0.10). However, consumption of chili peppers (P-Value=0.00) and
meat (P-Value=0.02) had a statistically significant association with H. pylori status. But, fish
consumption (P-Value=0.31) and consuming the food items while they were hot (in terms of food
temperature) (P-Value=0.07) were not associated with H. pylori status. Interestingly, frequency of
outside food consumption was highly associated with H. pylori status (P-Value=0.00). The
participant’s chronic gastric status (P-Value=0.00) and its frequency (P-Value=0.02) were
associated with their H. pylori status. Similarly, family history of peptic ulcer was associated with
H. pylori status (P-Value=0.00). Moreover, parasite (P-Value=0.00) and protozoa infestations (PValue=0.02) were associated with H. pylori status. But, helminth infection was not associated
with H. pylori status (P-Value=0.55). However, anti parasitic drug use was associated with H.
pylori status (P-Value=0.04). But, prior treatment of H. pylori was not associated with current H.
pylori status (P-Value=0.80). Participant’s H. pylori status was associated their spouses’ H. pylori
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infection status (P-Value=0.00). (Table 10)
The final multivariate logistic regression analysis results for the association of participant
characteristics and H. pylori status are shown in Table 11. As noted in the univariate analysis, the
SES as indicated by the car ownership remained associated with H. pylori status in the
multivariate analysis (OR: 1.10 95%CI: 1.02-1.39). Prevalence of H. pylori was highly associated
with chronic gastric ailments. (OR: 3.73 95%CI: 1.69-8.26). Smoking was also highly associated
with prevalence of H. pylori in this population (OR: 2.23 95%CI: 1.24-4.02). Similarly,
consumption of meat was a high risk factor of H. pylori infection (OR: 2.35 95%CI: 1.30-4.23).
As seen in the univariate analysis consumption of chili peppers was an important protective factor
against H. pylori infection (OR: 0.20 95%CI: 0.10-0.37). Drinking filtered or boiled water versus
non filtered or boiled water use was associated with H. pylori status. (OR: 1.05 95%CI: 1.011.23). Consumption of restaurant food was also associated with prevalence of H. pylori. (Table
11)
Table 10: Relationship between participant characteristics and H. pylori in Pune, India

Participant
characteristics
Gender
Female
Male
Education
Primary School
High School
University
Car ownership
Yes
No
Drinking water
Filtered / boiled
Not filtered / boiled
Disease status
Peptic ulcer
Stomach cancer
Controls

H. pylori (n= 350)
Present N (%)
Absent N (%)

Univariate
P-Value

98 (52)
82 (50)

89 (48)
81 (50)

0.74

78 (56)
59 (53)
43 (43)

61 (54)
52 (47)
57 (57)

0.12

99 (45)
81 (61)

118 (55)
52 (39)

0.00

104 (45)
76 (63)

125 (55)
45 (37)

0.00

115 (61)
8 (23)
57 (46)

75 (39)
27 (77)
68 (54)

0.00
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Participant
characteristics
Smoking
Yes
No
Snack with Alcohol
Yes
No
Not applicable
Chili pepper Consumption
Yes
No
Meat Consumption
Yes
No
Fish Consumption
Yes
No
Consumption of food
while it is hot
Yes
No
Frequency of outside food
consumption
Almost never
1 / week
2 / week
3 / week
Chronic gastric disease
Yes
No
Frequency of gastric
disease
Never
1 /month
1 /week
≥ 2 / week
Family history of ulcer
Yes
No
Parasite infestation
Yes
No
Protozoa infestation
Yes
No
Helminth infestation
Yes
No

H. pylori (n= 350)
Present N (%)
Absent N (%)

Univariate
P-Value

110 (57)
70 (44)

82 (43)
88 (56)

0.01

69 (57)
35 (56)
76 (46)

52 (43)
27 (44)
91 (54)

0.10

87 (42)
93 (66)

122 (58)
48 (34)

0.00

87 (61)
93 (45)

55 (39)
115 (55)

0.00

52 (56)
128 (50)

41 (44)
129 (50)

0.31

90 (57)
90 (47)

68 (43)
102 (53)

0.07

99 (42)
18 (56)
32 (76)
31 (77)

137 (58)
14 (44)
10 (24)
9 (23)

0.00

127 (59)
53 (40)

89 (41)
81 (60)

0.00

76 (46)
52 (67)
33 (47)
19 (50)

88 (54)
26 (33)
37 (53)
19 (50)

0.02

62 (63)
118 (47)

37 (37)
133 (53)

0.00

69 (42)
111 (59)

94 (58)
76 (41)

0.00

86 (46)
94 (58)

102 (54)
68 (42)

0.02

46 (48)
134 (53)

49 (52)
121 (47)

0.55
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Participant
characteristics
Anti-parasitic drug use
Yes
No
H. pylori treatment kit
used
Yes
No
Spouses’ H. pylori
infection status
Yes
No
Don’t know

H. pylori (n= 350)
Present N (%)
Absent N (%)

Univariate
P-Value

107 (57)
73 (45)

82 (43)
88 (55)

0.04

46 (50)
134 (52)

46 (50)
124 (48)

0.80

29 (78)
40 (75)
111 (43)

8 (22)
13 (25)
149 (57)

0.00

Table 11: Multivariate model: Relationship between participant characteristics and H. pylori In
Pune, India
Participant
characteristics
Car ownership
Yes
No
Parasite infestation
Yes
No
Chronic gastric disease
Yes
No
Chili pepper
Consumption
Yes
No
Meat Consumption
Yes
No
Smoking
Yes
No
Eating outside
3 / week
2 / week
1 / week
Almost never
Water source
Filtered / boiled
Not filtered / boiled

Adjusted
Odds ratio
1
1.10

95% Confidence
interval

P value

1.02 – 1.39

0.05

0.44
1

0.24 – 0.80

0.00

3.73
1

1.69 – 8.26

0.00

0.20
1

0.10 – 0.37

0.00

2.35
1

1.30 – 4.23

0.00

2.23
1

1.24 - 4.02

0.00

3.77
2.69
1.61
1

1.39 - 10.23
1.18 - 7.42
0.65 – 3.98

0.01

1.01 – 1.23

0.05

1
1.05
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We could enroll only 35 gastric cancer patients in this study. Also, the probability of H. pylori
thriving in the stomach lining with the metaplasia is low. Hence due to their inadequate sample
size and to avoid bias, we have eliminated these 35 patients from the analysis investigating
association between participants’ disease status and various risk factors.
In the initial univariate analysis, demographic characteristics such as gender (P-Value=0.42),
education (P-Value=0.23), age were not associated with disease status. Study participant’s
disease status (having peptic ulcer versus not having any gastric ailment) was associated with H.
pylori (P-Value=0.01). Study participant’s current tobacco use was not associated with disease
status (P-Value=0.16). Participants’ consumption of snacks while drinking alcohol was associated
with disease status (P-Value=0.00). Consumption of chili peppers (P-Value=0.06) did not have a
statistically significant association with disease status. But, consuming the food items while they
were hot (in terms of food temperature), meat (P-Value=0.02) and fish (P-Value=0.01) was
associated with disease status (P-Value=0.04). Frequency of outside food consumption was not
associated with disease status (P-Value=0.30). Participants’ Family history of peptic ulcer was
associated with disease status (P-Value=0.04). Parasite (P-Value=0.56), protozoa (P-Value=0.20)
and helminth (P-Value=0.25) infestations were not associated with disease status. Prior treatment
of H. pylori was associated with current disease status (P-Value=0.03). Participant’s disease
status was associated their spouses’ H. pylori infection status (P-Value=0.00). (Table 12)
The final multivariate logistic regression analysis results for the association of participant
characteristics and disease status are shown in Table 13. As noted in the univariate analysis,
participants H. pylori status remained associated with disease status in the multivariate analysis
(OR: 1.70 95%CI: 1.03-2.89). Participants disease status was associated with consumption of
meat (OR: 1.10 95%CI: 1.02-1.75). Similarly, participants disease status was associated with
consumption of fish (OR: 1.05 95%CI: 1.02-1.89). Similarly, participants’ positive family history
of ulcer was a risk factor of their peptic ulcer status (OR: 1.20 95%CI: 1.08-1.60). As seen in the
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univariate analysis history of anti parasite drug use was an important protective factor against
peptic ulcer prevalence (OR: 0.51 95%CI: 0.30-0.86). Similarly, consumption of snacks with
alcohol remained an important protective factor against peptic ulcer in this study population (OR:
0.32 95%CI: 0.13-0.78). (Table 13)
Table 12: Relationship between participant characteristics and disease status (peptic ulcer vs.
control) in Pune, India
Participant
characteristics
Gender
Female
Male
Education
Primary School
High School
University
H. pylori status
Positive
Negative
Smoking
Yes
No
Snack with Alcohol
Yes
No
Not applicable
Chili peppers Consumption
Yes
No
Meat Consumption
Yes
No
Fish Consumption
Yes
No
Consumption of food while
it is hot
Yes
No
Outside food consumption
Almost never
1 / week
2 / week
3 / week

Disease status (n = 315)
Control N (%) Peptic ulcer N (%)

Univariate
P-Value

62 (37)
63 (42)

104 (63)
86 (53)

0.42

45 (35)
40 (41)
40 (46)

85 (65)
58 (59)
47 (54)

0.23

57 (33)
68 (47)

115 (67)
75 (52)

0.01

63 (36)
62 (44)

112 (64)
78 (56)

0.16

44 (39)
9 (17)
72 (48)

68 (61)
45 (83)
77 (52)

0.00

65 (35)
60 (46)

119 (65)
71 (54)

45 (39)
80 (42)

94 (61)
96 (58)

0.02

11 (12)
114 (51)

78 (88)
112 (49)

0.01

50 (34)
75 (45)

99 (66)
91 (55)

0.04

90 (43)
12 (39)
13 (32)
10 (29)

119 (57)
19 (61)
28 (68)
24 (71)

0.30

0.06
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Participant
characteristics
Family history of ulcer
Yes
No
Parasite infestation
Yes
No
Protozoa infestation
Yes
No
Helminth infestation
Yes
No
H. pylori treatment kit used
Yes
No
Spouses’ H. pylori
infection status
Yes
No
Don’t know

Disease status (n = 315)
Control N (%) Peptic ulcer N (%)

Univariate
P-Value

31 (31)
94 (44)

68 (69)
122 (56)

0.04

55 (38)
70 (41)

91 (62)
99 (59)

0.56

61 (36)
64 (44)

107 (64)
83 (56)

0.20

30 (34)
95 (42)

58 (66)
132 (58)

0.25

42 (49)
83 (36)

43 (51)
147 (64)

0.03

25 (68)
0 (0)
100 (43)

12 (32)
43 (100)
135 (57)

0.00

Table 13: Multivariate model: Relationship between participant characteristics and disease status
(peptic ulcer vs. control) in Pune , India
Participant
characteristics
H. pylori status
Positive
Negative
Snack with Alcohol
Yes
No
Meat Consumption
Yes
No
Fish Consumption
Yes
No
Family history of
ulcer
Yes
No
Anti-parasitic drug
use
Yes
No

Adjusted
Odds ratio

95% Confidence
interval

P value

1.70
1

1.03 – 2.89

0.04

0.32
1

0.13 - 0.78

0.00

1.10
1

1.02 – 1.75

0.05

1.05
1

1.02 – 1.89

0.05

1.20
1

1.08 – 1.60

0.04

0.51
1

0.30 - 0.86

0.01
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In this study we used prevalence of chronic gastric disease as a surrogate measure of gastric
pathology in general. In this study we tried to shed more light on the relationship between gastric
disease and risk factors such as education, spicy food consumption, consumption of high
temperature food, intestinal parasite drug use, etc.
In the initial univariate analysis, demographic characteristics such as gender (P-Value=0.80),
education (P-Value=0.10), age were not associated with chronic gastric disease status. Study
participant’s disease status (having peptic ulcer or stomach cancer versus not having any of these
gastric ailments) was associated with chronic gastric disease (P-Value=0.03). Study participant’s
H. pylori status was associated with chronic gastric disease (P-Value=0.00). Study participant’s
current tobacco use was not associated with chronic gastric disease (P-Value=0.58). Participants’
consumption of snacks while drinking alcohol was not associated with chronic gastric disease
status (P-Value=0.73). However, consumption of meat (P-Value=0.04) and fish (P-Value=0.03)
had a statistically significant association with chronic gastric disease status. But, chili peppers
consumption (P-Value=0.57) was not associated with chronic gastric disease status. However,
consuming the food items while they were hot (in terms of food temperature) was associated with
chronic gastric disease status (P-Value=0.00). Interestingly, frequency of outside food
consumption was not associated with chronic gastric disease (P-Value=0.67). Family history of
peptic ulcer was associated with chronic gastric disease status (P-Value=0.00). Parasite (PValue=0.23), protozoa (P-Value=0.51) and helminth infestations (P-Value=0.34) were not
associated with chronic gastric disease status. (Table 14)
The final multivariate logistic regression analysis results for the association of participant
characteristics and chronic gastric disease status are shown in Table 15. As noted in the univariate
analysis, participants H. pylori status remained strongly associated with chronic disease status in
the multivariate analysis (OR: 2.48 95%CI: 1.24-4.96). Participants chronic gastric disease status
was highly associated with consumption of meat (OR: 1.05 95%CI: 1.03-1.78). Similarly,
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participants disease status was highly associated with consumption of fish (OR: 1.09 95%CI:
1.06-1.90). Similarly, participants’ positive family history of ulcer was a high risk factor of their
chronic disease status (OR: 4.45 95%CI: 1.95-10.15). As seen in the univariate analysis history of
anti parasite drug use was a protective factor against peptic ulcer prevalence (OR: 0.43 95%CI:
0.21-0.89). (Table 15)
Table 14: Relationship between participant characteristics and chronic gastric disease status in
Pune, India

Participant
characteristics
Gender
Female
Male
Education
Primary School
High School
University
Disease status
Peptic ulcer
Stomach cancer
Controls
H. pylori status
Positive
Negative
Smoking
Yes
No
Snack with Alcohol
Yes
No
Not applicable
Chili peppers
Consumption
Yes
No
Meat Consumption
Yes
No
Fish Consumption
Yes
No

Chronic gastric disease (n=350)
Present N (%)
Absent N (%)

Univariate
P-Value

114 (61)
102 (63)

73 (39)
61 (37)

0.82

90 (65)
73 (66)
53 (53)

49 (35)
38 (34)
47 (47)

0.10

126 (66)
15 (43)
75 (60)

64 (34)
20 (57)
50 (40)

0.03

127 (70)
89 (52)

53 (30)
81 (48)

0.00

121 (63)
95 (60)

71 (37)
63 (40)

0.58

78 (65)
38 (61)
100 (60)

43 (35)
24 (39)
67 (40)

0.73

126 (60)
90 (64)

83 (40)
51 (36)

0.57

97 (68)
119 (57)

45 (31)
89 (43)

0.04

72 (88)
144 (56)

21 (22)
113 (44)

0.03
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Participant
characteristics
Consumption of food
while it is hot
Yes
No
Frequency of outside
food consumption
Almost never
1 / week
2 / week
3 / week
Family history of
ulcer
Yes
No
Parasite infestation
Yes
No
Protozoa infestation
Yes
No
Helminth infestation
Yes
No

Chronic gastric disease (n=350)
Present N (%)
Absent N (%)

Univariate
P-Value

116 (73)
100 (52)

42 (27)
92 (48)

0.00

141 (60)
21 (66)
29 (69)
25 (63)

95 (40)
11 (34)
13 (31)
15 (37)

0.67

84 (85)
132 (53)

15 (15)
119 (47)

0.00

95 (58)
121 (65)

68 (42)
66 (35)

0.23

113 (60)
103 (64)

75 (40)
59 (36)

0.51

63 (66)
153 (60)

32 (34)
102 (40)

0.34

Table 15: Multivariate model: Relationship between participant characteristics and chronic gastric
disease in Pune, India
Participant
characteristics
H. pylori status
Positive
Negative
Meat Consumption
Yes
No
Fish Consumption
Yes
No
Family history of
ulcer
Yes
No
Anti-parasitic drug
use
Yes
No

Adjusted
Odds ratio

95% Confidence
interval

P value

2.48
1

1.24 – 4.96

0.00

1.05
1

1.03 – 1.78

0.05

1.09
1

1.06 – 1.90

0.05

4.45
1

1.95 – 10.15

0.04

0.43
1

0.21 - 0.89

0.02
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We followed a cohort of 100 participants who were H. pylori positive for two years. Eighty
percent (80/100) of these individuals were suffering from peptic ulcer and 20 % (20/100) were
from the control group. The median age was 45 years (range: 28-63years). Forty five percent
(45/100) were females while 55% (55/100) were males. All the participants of this cohort took
medications for the treatment of H. pylori infection. However, only 75% (75/100) opted for a test
to check their H. pylori status after finishing their treatment. Interestingly, treatment against H.
pylori status was changed from initial positive to negative in only 53% of these (40/75)
individuals. H. pylori infection was eradicated in 50% (35/70) of individuals who opted for the
antibiotic therapy. (Figure 4) However, 40% (40/100) of individuals reported alleviation of initial
gastric ailments within 6 months of completing the treatment. [Median time: 2 month (range: 1
month – 6 month)]. Seventy percent (70/100) of individuals took the anti H. pylori triple therapy
(H. pylori treatment kit) while 20% (20/100) of participants opted for traditional herbal treatment
and only 10 % (10/100) choose other remedies. Interestingly, only 10% (10/100) individuals that
were diagnosed of H. pylori sought a specialist (gastro-enterologist) consultation. (Table 16)
Table 16: Prospective cohort participant characteristics in Pune, India (N=100)
Characteristics
Disease status
Peptic ulcer
Controls
Median age (Range)
Gender
Female
Male
H. pylori treatment taken
Yes
No
H. pylori diagnostic test taken after
treatment
Yes
No
H. pylori status changed from positive
to negative after treatment
Yes
No
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N (%)
80 (80)
20 (20)
45 years (range: 28-63)
45 (45)
55 (55)
100 (100)
0 (0)

75 (75)
25 (25)

40 (53)
35 (47)

Characteristics
Gastric complaints are alleviated after
treatment
Yes
No
Type of treatment taken
Antibiotics (H. pylori treatment kit)
Herbal
Other
Sought gastro-enterologists’
consultation
Yes
No

N (%)

40 (40)
60 (60)
70 (70)
20 (20)
10 (10)

10 (10)
90 (90)

Anti H. pylori treatment
taken
Antibiotics (n=70)
Herbal (n=20)
Other (n=10)

H. pylori diagnostic
test taken after
treatment
N =75
Antibiotics (n =70)
Herbal (n=5)

H. pylori eradicated
after treatment
N = 40

H. pylori eradicated
after antibiotics
treatment
N = 35

H. pylori eradicated
after herbal treatment
N=5

Figure 4 Anti H. pylori treatment success in Pune, India
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Discussion
This is the first study to document the prevalence of H. pylori among patients with peptic ulcer,
stomach cancer and healthy individuals in Pune, Maharashtra. To our knowledge this is also the
largest study (n=350) investigating risk factors of H. pylori prevalence in the state of
Maharashtra, India.
H. pylori infection is one of the most common infections worldwide. Epidemiological studies
from India have shown 70%,[230] 77.2%,[223] 78% [231] and 79% [24] prevalence of H. pylori
infection. In the present study, the prevalence of H. pylori infection was 61% in symptomatic and
45 % in asymptomatic individuals. The prevalence of H. pylori infection was independent of
gender in the present study, which is consistent with previous reports. [24] Similarly, we found
no association between age and prevalence of H. pylori infection. However, in most of the studies
from developing countries it’s noted that within first 10 years of life the prevalence of H. pylori
increases with age. [77, 232-238] It is important to note that we enrolled only adults in our study
in India. Hence we were unable to note the association between age and prevalence of H. pylori
in our study. In some studies, lower education has shown to be associated with high prevalence of
H. pylori.[130, 239, 240] In our study education was not associated with prevalence of H. pylori.
This association should be explored in a larger and more diverse cohort of individuals, perhaps
recruiting individuals from villages near to Pune city as none of the participants in our study were
uneducated. We recruited participants from the city of Pune and the educational attainment in our
study cohort represents the education level of general population of Pune city.
There is no doubt that improvements in the standards of living are an important factor in changing
the risk factors related to H. pylori infection. A recent study has shown a sharp decrease of
prevalence of H. pylori infection in St. Petersburg, Russia, comparing the prevalence in children
in 1995 and 2005. [14] Another example that improvements in the standards of living are related
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to H. pylori infection was reported by Parente et al.,[241] who compared the prevalence in
children of low and high socioeconomic situation living in the same neighborhood in Terezina,
Brazil. While in children 5–6 years old from low socioeconomic class, the prevalence reached
70%, in the high socioeconomic class it was 17.4% .[241] H. pylori infection is related to social
class, being higher in low social class. The leading hypothesis for H. pylori transmission is person
to person via contact with either gastric or fecal contents. The increasing prevalence of H. pylori
infection with age in most of the places probably reflects the infection acquired at different ages
as a result of poor sanitation facilities and hygienic practices as well as crowding during
childhood. Water supply seems to be an important source of H. pylori infection. Klein et al. have
shown in Lima, Peru that children whose homes had an external water source were three times
more likely to be infected than children living in homes provided with internal water source. [79]
Nurgalieva et al. reported that drinking river water had highest risk for H. pylori infection
compared to tap water, suggesting that transmission of H. pylori infection can be water borne.
[242]
The importance of drinking river water as a transmission route of H. pylori was emphasized by
Fujimura et al. in Japan, who collected samples from four rivers (upper middle and downstream).
H. pylori was detected by nested polymerase chain reaction in the water of middle and
downstream, suggesting that river water in the natural environment could be a risk factor for H.
pylori transmission.[106] Using a bivariate analysis, Rodrigues et al. showed in children from an
urban community in northeast Brazil a positive correlation between type of drinking water and H.
pylori infection.[146] Boiling the water seems to be an effective way to prevent the infection, as
suggested by Sung .[243] Our results confirm that source of drinking water is a risk factor for H.
pylori infection. Prevalence was higher when the source of drinking water was a river and lower
when the water was filtered or boiled [OR 1.05 (95% CI = 1.01–1.23)].
We also found that, the increasing frequency of eating outside was significantly associated with
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prevalence of H. pylori in our study population. (Table 11) In developing countries, it is well
known that eating restaurant food favors a feco-oral route transmission. SES has been considered
as an important risk factor for H. pylori infection, probably because SES relates to hygienic
practices. The prevalence of H. pylori infection has been shown to be influenced by SES in
previous studies; [24, 244, 245] similarly, it was dependent on SES in the present study.[31] Car
ownership is a significant indicator of SES in state of Maharashtra and in Pune city. Specifically,
in our study, individuals who owned a car were less likely to have H. pylori infection compared
with participants who did not own a car (OR: 1.10 95% CI: 1.02-1.39).
Meat has shown to be a risk factor for H. pylori infection in numerous studies. [117, 246-248]
Consumption of meat was a significant risk factor for H. pylori infection in our study as well.
[OR 2.35 (95% CI = 1.30–4.23)].On the other hand, consumption of chili peppers was shown to
have a protective effect against H. pylori infection. In Maharashtra and in Pune chili peppers are
common ingredients of most of the recipe. The chili peppers are added with turmeric (Curcuma
longa) and cooking oil while preparing food items from produce. Previous studies have shown the
protective effect of turmeric, chili peppers and some spices against H. pylori infection. [70]
Several in vitro studies have looked at the effect of plant extracts on H. pylori. Anti-microbial
effects have been reported for garlic [67], green tea [249], honey [250], thyme [251], some
Iranian plants [252] and the essential oils from several species of mint [252]. Some of these
studies have been validated in animals and confirmed the potential benefit of using plants as the
source of anti-microbial agents against H. pylori. [70] However, the exact mechanism behind the
bactericidal action of chili peppers has not been validated. Certainly, more work needs to be done
in determining the active ingredients of chili peppers as well as performing studies on a larger
number of patients.
In our study 27 % participants were infected with helminth and 54% with protozoa and 47 % had
some kind of parasite infection. Parasite infection was the only protective factor that remained
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statically significant in the multivariate model. Parasite infestation is seen as another protective
factor against diseases caused by H. pylori infection. In our study individuals who suffered from
parasite infestations were less likely to have H. pylori infection. Moreover, individuals who had
history of an anti parasite drug were less likely to have a peptic ulcer or a chronic gastric ailment.
Indeed its hypothesized that concurrent enteric helminth infection can attenuate gastric atrophy
via immune modulation. [71, 169]
It is well known that the immune response to infectious agents leads to the expansion of particular
CD4+ve T‐helper (Th) cell subsets. Th1 cells are reported to produce Interleukin (IL)–2, IL‐12
and interferon γ (IFNγ), and are associated with cell‐mediated immunity, while Th2 cells have
been reported to secrete Il‐4, IL‐5, IL‐6, IL‐10 and IL‐13, and are responsible for strong antibody
responses, including IgE‐dependent allergies of the immediate type.[253] In general, Th1
responses are associated with intracellular micro‐organisms including bacteria, protozoa and
fungi, whereas extracellular pathogens induce Th2 responses. Studies to date have shown that
natural infection with H. pylori, which is by and large an extracellular infection, leads to a
Th1‐predominant response, with IL‐2, IL‐12, TNFα and IFNγ reported to be present in the gastric
mucosa of H. pylori‐positive subjects. [254-256] In contrast, the Th2 cytokines IL‐4 and IL‐5

have been found to be virtually absent in H. pylori infected subjects although a number of studies
have reported IL‐10 to be present in the gastric mucosa of subjects with H. pylori‐related active
gastritis.[256-259]
Recently, Fox et al.[169] showed that mice infected with Helicobacter felis alone showed a Th1
response, but in mice co‐infected with H. felis and the helminth H. polygyrus, there was a shift to
a pattern of cytokine expression consistent with a Th2 immune response.[71] This corresponded
to a significant reduction in mucosal hyperplasia, mucosal metaplasia and glandular atrophy.
Thus, associated with the Th2 immune response, there was a marked reduction in
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Helicobacter‐associated corpus atrophy, despite chronic inflammation and high Helicobacter
colonization. If this is extrapolated to man, then intestinal helminth infection may provide a
protective effect against development of gastric atrophy and gastric cancer. [71] Given that
animal models do not necessarily replicate the human situation, Fox's study, indicates the
complexity of biological actions associated with H. pylori which merits further investigation.
In our study, H. pylori were seen as a significant risk factor for peptic ulcer disease. [OR: 1.70
(95% CI: 1.03- 2.89)] as well as chronic gastric disease [OR: 2.48 (95% CI: 1.24- 4.96)]. The
recognition of H. pylori infection as the main cause of ulcer [260] was undoubtedly the most
important achievement in the past 50 years in gastroenterology. Showing that ulcer was a curable
disease with a short treatment schedule represented a blessing to millions of people. [261-264]
Lately, it was recognized that not only ulcer was related to H. pylori infection, but also the
majority of gastric cancer [1, 265-267] and gastric mucosa-associated lymphoid tissue (MALT)
lymphoma [268, 269]. Indeed eradication of H. pylori would probably be a very important tool in
the management of upper digestive disease, particularly looking on high-risk cancer population.
In our study, consumption of meat is suggested to be an important risk factor peptic ulcer. [OR:
1.10 (95% CI: 1.02- 1.75)] and chronic gastric disease [OR: 1.05 (95% CI: 1.03- 1.78)].
Consumption of fish has also shown to be an important risk factor peptic ulcer. [OR: 1.05 (95%
CI: 1.02- 1.89)] and chronic gastric disease [OR: 1.09 (95% CI: 1.06- 1.90)]. It is well known that
individuals consume smoked, dried salted meat and fish mostly outside homes (in restaurants) in
Pune. These put them at increased risk of acquiring H. pylori infection which may contribute to
development of gastric pathologies such as peptic ulcer and or stomach cancer. Our findings are
line with many other researchers who showed that consumption of smoked meat, salted fish and
meat are risk factors for various gastric ailments including stomach cancer. Smoke-drying and
preservation leads to formation of N-nitroso compounds. Nitrite reacts with amines and amides
found in meats and other proteins to form N-nitroso compounds, which are animal carcinogens
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and possible human carcinogens.[270] Furthermore, although salt is not an independent
carcinogen, it is thought to increase the risk of gastric cancer through direct damage to the gastric
mucosa, which results in gastritis, increased DNA synthesis, and cell proliferation.[271] This
indirectly contributes to the development of chronic atrophic gastritis, leading to the development
of stomach cancer. [121, 123, 272-276] Because of the presence of both salt and nitrite in
processed fish and meats, its role in the development of stomach cancer cannot be ignored, as was
found in the present study. Studies in the past have also shown positive associations of high
intake of processed meats as a group or for individual cured meats. [277-282]
Family history of ulcer has also shown to be a statistically significant risk factor for peptic ulcer
[OR: 1.20 (95% CI: 1.08- 1.60)] and chronic gastric disease [OR: 4.45 (95% CI: 1.95- 10.15)] in
our study. Positive family history of peptic ulcer has been well recognized as significant risk
factor for peptic ulcer. [283-285]
Alcohol and tobacco consumption did not emerge as a risk factor for peptic ulcer and chronic
gastric disease in our study. However, consumption of snacks with alcohol was a statistically
significant protective factor against peptic ulcer [OR: 0.32 (95% CI: 0.13- 0.78)]. This can be
partially be explained by the link of type, amount of alcohol consumed by individuals from
various socio economic strata. Usually individuals from higher SES strata consume snacks with
alcohol; these individuals may be drinking in moderation and may be opting for treatment for
their ailments compared to individuals from lower SES who don’t snack with their alcohol. These
factors may be interlinked and may play a role in protection of gastric mucosal layer in people
who drink but consume snacks while drinking. However, this hypothesis needs to be formally
investigated.
In our study we also followed a cohort of H. pylori positive individuals for approximately 2 years.
All the 100 individuals opted for some kind of treatment to treat their H. pylori infection.
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However, only 75% (75/100) opted for a test to check their H. pylori status after finishing their
treatment. Interestingly, treatment against H. pylori status was changed from initial positive to
negative in only 53% of these (40/75) individuals. This may reflect the poor success of H. pylori
eradication by the triple therapy or by the herbal medicines that were used to treat H. pylori. The
antimicrobial resistance of H. pylori is on the rise across the globe and is well documented in
India. [28, 286-299] It is frequently observed that patients buy only a part of the H. pylori
treatment kit or use only the half and once their symptoms are alleviated they share the rest of the
kit with their friends and family members (personal observation). These facts certainly merit
attention and patient education should be made a mandatory part while prescribing anti microbial
agents.
Our study has some limitations. First we were not successful in enrolling the desired number of
patients (n=50) diagnosed with stomach cancer. We believe this is owing to the facts related to
high mortality rate among individuals diagnosed with stomach cancer in India and also to low
proportion of patients diagnosed with stomach cancer seeking active treatments. Future studies
need to utilize innovative strategies such as individual patient counseling and organizing patient
education seminars to boost enrollment of patients diagnosed with stomach cancer into research
studies. We came across a lot of missing data for the amount of cigarettes and alcohol consumed
by the participants. We believe owing to the stigma attached to smoking and alcohol consumption
individuals participating in this study were reluctant to share the amount of alcohol and tobacco
consumed by them. Hence, we were unable to investigate the dose response of tobacco and
alcohol consumption. We also made an attempt to elucidate the intra-familial transmission
pathways of H. pylroi by enquiring about spouses’ H. pylori status. Unfortunately 74% of our
participant did not know H. pylori status of their spouse. Almost all of them reported that their
spouse was never tested for presence of H. pylori. Lastly, owing to the financial restraints and
non availability of technical expertise required for isolation of DNA from stool samples and
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genotyping were unable to conduct the genotyping of H. pylori to detect the prevalence of CagA
positive and furthermore East Asian CagA H. pylori infection in Pune. This area certainly needs
attention as previous studies from India have shown high prevalence of CagA positive H. pylori
among symptomatic population.
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Chapter Five
Conclusions
Our studies in Ecuador and Panama documented the prevalence of virulent East Asian CagA
positive H. pylori among healthy individuals. This finding is of utmost importance in
understanding the patho-physiology of stomach cancer in Ecuador and Panama. It is well
documented that the grades of inflammation, activity of gastritis, and atrophy are significantly
higher in gastritis patients infected with the East Asian CagA-positive strain than in gastritis
patients infected with the CagA-negative or Western CagA-positive strains. [300-303] The
prevalence of the East Asian CagA-positive strain is associated with the mortality rate of gastric
cancer in Asia. Endemic circulation of H. pylori populations carrying biologically more active
CagA proteins in East Asian countries, where the mortality rate of gastric cancer is among the
highest in the world, may be involved in increasing the risk of gastric cancer in populations such
as of Ecuador and Panama. [304-306] This can explain the difference between the incidence rate
of stomach cancer in Ecuador and Panama. Our study from Pune, India underscores H. pylori
along with family history of peptic ulcer, meat and fish consumption as significant risk factors for
peptic ulcer and chronic gastric disease. Our study in India also confirms low SES along with
meat consumption and tobacco smoking as one of the risk factors for H. pylori infection. We also
highlight the statistically significant association of increased frequency of eating restaurant food
and drinking non filtered water as risk factors for H. pylori infection. These may suggest the fecooral and water-born transmission of H. pylroi in Pune, India. Interestingly we also bring to light
the role of chili peppers consumption as protective factor against H. pylori infection. Last but not
the least we emphasize the protective influence of concurrent parasite infestation on H. pylori

73

infection and development of chronic gastric ailments. This underscores the need of research to
investigate the relationship of various dietary factors especially chili peppers and other protective
factors such as parasite infestation and H. pylori infection in developing countries.
In summary, the speculations in this paper are based on objective scientific evidence that fits with
the changing patterns of peptic ulcer and gastric cancer that we have seen. We recommend studies
in countries like India and Ecuador to investigate the epidemiology of specific types of parasite
infections as well as the influence of diet, host genetic susceptibility, H. pylori genotype and other
co-morbidity states in determining gastric cancer rates. Moreover, the protective effect of
concurrent parasite infection on the development of pre-neoplastic lesions such as gastric atrophy
should be extended to studies on gastric cancer. We have highlighted the protective role of chili
peppers against H. pylori infection. Although the bactericidal and anti-adhesive effects of chili
peppers, ginger, cumin, and turmeric, have been shown in vitro, further studies are needed to be
carried out to investigate their effects in vivo, to see whether the extracts are able to remain
effective despite the harsh process of digestion. Lastly, the issues of treatment compliance leading
to anti microbial resistance are also equally vital and need to be studied in larger population based
studies.
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